10-Q

Large accelerated filer

Accelerated filer

Non-accelerated filer

☐ (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

0001193125-17-253956.txt : 20170810 0001193125-17-253956.hdr.sgml : 20170810 20170810111059 ACCESSION NUMBER: 0001193125-17-253956 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170810 DATE AS OF CHANGE: 20170810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stereotaxis, Inc. CENTRAL INDEX KEY: 0001289340 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943120386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36159 FILM NUMBER: 171020283 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-678-6100 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 10-Q 1 d439571d10q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2017

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36159

STEREOTAXIS, INC.

(Exact name of registrant as specified in its charter)


Delaware		94-3120386
(State of Incorporation)		(I.R.S. employer identification no.)

4320 Forest Park Avenue Suite 100 St. Louis, Missouri		63108
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (314) 678-6100

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Registration S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company, “and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b -2 of the Exchange Act). ☐ Yes ☒ No

The number of outstanding shares of the registrant’s common stock on July 31, 2017 was 22,753,121.

STEREOTAXIS, INC.

INDEX TO FORM 10-Q


		Page
Part I Financial Information
Item 1.	Financial Statements (unaudited)
	Balance Sheets		3
	Statements of Operations		4
	Statements of Cash Flows		5
	Notes to Financial Statements		6-16
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		17-23
Item 3.	[Reserved]		23
Item 4.	Controls and Procedures		23
Part II Other Information
Item 1.	Legal Proceedings		24
Item 1A.	Risk Factors		24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		24
Item 3.	Defaults upon Senior Securities		24
Item 4.	[Reserved]		24
Item 5.	Other Information		24
Item 6.	Exhibits		24
Signatures			25
Exhibit Index			26

ITEM 1.

FINANCIAL STATEMENTS

STEREOTAXIS, INC.

BALANCE SHEETS


	June 30,			December 31,
	2017			2016
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	5,035,463		$	8,501,392
Accounts receivable, net of allowance of $603,588 and $379,817 in 2017 and 2016, respectively		4,876,716			4,665,959
Inventories		4,984,115			5,381,103
Prepaid expenses and other current assets		617,412			855,295

Total current assets		15,513,706			19,403,749
Property and equipment, net		792,367			1,086,244
Intangible assets, net		336,908			436,569
Other assets		41,047			39,241

Total assets	$	16,684,028		$	20,965,803

Liabilities and stockholders’ deficit
Current liabilities:
Accounts payable	$	1,737,247		$	2,623,010
Accrued liabilities		3,887,511			4,491,164
Deferred revenue		8,101,667			8,751,336
Warrants		16,357,444			19,787,007

Total current liabilities		30,083,869			35,652,517
Long-term deferred revenue		377,076			522,329
Other liabilities		321,316			320,409

Total liabilities		30,782,261			36,495,255
Convertible Preferred stock:
Convertible Preferred stock, par value $0.001; 10,000,000 shares authorized, 23,900 shares outstanding at 2017 and 2016		5,960,475			5,960,475
Stockholders’ deficit:
Common stock, par value $0.001; 300,000,000 shares authorized, 22,612,043 and 22,063,582 shares issued at 2017 and 2016, respectively		22,612			22,064
Additional paid in capital		450,370,408			449,939,406
Treasury stock, 4,015 shares at 2017 and 2016		(205,999	)		(205,999	)
Accumulated deficit		(470,245,729	)		(471,245,398	)

Total stockholders’ deficit		(20,058,708	)		(21,489,927	)

Total liabilities and stockholders’ deficit	$	16,684,028		$	20,965,803

See accompanying notes.

STEREOTAXIS, INC.

STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2017			2016			2017			2016
Revenue:
Systems	$	1,828,439		$	935,978		$	2,047,334		$	3,010,997
Disposables, service and accessories		6,638,587			6,938,645			13,397,364			13,511,632

Total revenue		8,467,026			7,874,623			15,444,698			16,522,629
Cost of revenue:
Systems		920,517			395,898			1,140,961			1,478,996
Disposables, service and accessories		1,281,729			699,173			2,317,911			1,796,888

Total cost of revenue		2,202,246			1,095,071			3,458,872			3,275,884
Gross margin		6,264,780			6,779,552			11,985,826			13,246,745
Operating expenses:
Research and development		1,281,264			1,421,380			2,439,697			2,894,465
Sales and marketing		3,472,619			4,211,706			7,098,219			8,105,819
General and administrative		1,945,676			2,786,046			4,785,546			5,372,838

Total operating expenses		6,699,559			8,419,132			14,323,462			16,373,122

Operating loss		(434,779	)		(1,639,580	)		(2,337,636	)		(3,126,377	)
Other income		300,255			135,370			3,429,563			166,664
Interest income		1			140			9			362
Interest expense		(42,776	)		(829,046	)		(92,267	)		(1,648,066	)

Net income (loss)	$	(177,299	)	$	(2,333,116	)	$	999,669		$	(4,607,417	)
Cumulative dividend on convertible preferred stock		(369,661	)		—			(732,849	)		—
Net income attributable to convertible preferred stock		—			—			(167,539	)		—

Earnings (net loss) attributable to common stockholders	$	(546,960	)	$	(2,333,116	)	$	99,281		$	(4,607,417	)

Earnings (net loss) per common share:
Basic	$	(0.02	)	$	(0.11	)	$	0.00		$	(0.21	)
Diluted	$	(0.02	)	$	(0.11	)	$	0.00		$	(0.21	)

Weighted average shares used in computing earnings (net loss) per common share:
Basic		22,581,330			21,793,583			22,450,392			21,702,597
Diluted		22,581,330			21,793,583			22,458,479			21,702,597

See accompanying notes.

STEREOTAXIS, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)


	Six Months Ended June 30,
	2017			2016
Cash flows from operating activities
Net earnings (loss)	$	999,669		$	(4,607,417	)
Adjustments to reconcile net earnings (loss) to cash used in operating activities:
Depreciation		277,402			185,802
Amortization of intangibles		99,661			99,660
Amortization of deferred finance costs		49,588			108,850
Share-based compensation		412,678			566,975
Loss on asset disposal		20,772			—
Adjustment of warrants		(3,429,563	)		(166,664	)
Changes in operating assets and liabilities:
Accounts receivable		(210,757	)		1,318,967
Inventories		396,988			(806,755	)
Prepaid expenses and other current assets		288,295			147,942
Other assets		(1,806	)		(13,081	)
Accounts payable		(885,763	)		587,562
Accrued liabilities		(603,653	)		(627,335	)
Deferred revenue		(794,922	)		(1,398,213	)
Other liabilities		907			(5,307	)

Net cash used in operating activities		(3,380,504	)		(4,609,014	)
Cash flows from investing activities
Purchase of fixed assets		(4,297	)		—

Net cash used in investing activities		(4,297	)		—
Cash flows from financing activities
Payments of deferred financing costs		(100,000	)		(100,000	)
Proceeds from (payments of) revolving line of credit		—			3,000,000
Payments of Healthcare Royalty Partners debt		—			(23,709	)
Proceeds from issuance of stock, net of issuance costs		18,872			(2,770	)

Net cash provided by (used in) financing activities		(81,128	)		2,873,521

Net increase (decrease) in cash and cash equivalents		(3,465,929	)		(1,735,493	)

Cash and cash equivalents at beginning of period		8,501,392			5,593,582

Cash and cash equivalents at end of period	$	5,035,463		$	3,858,089

See accompanying notes.

STEREOTAXIS, INC.

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

Notes to Financial Statements

In this report, “Stereotaxis”, the “Company”, “Registrant”, “we”, “us”, and “our” refer to Stereotaxis, Inc. and its wholly owned subsidiaries. Epoch^®, Niobe^®, Odyssey^®, Odyssey Cinema™, Vdrive^®, Vdrive Duo™, V-CAS™, V-Loop™, V-Sono™, V-CAS Deflect™, QuikCAS™, Cardiodrive^®, and Pegasus™ are trademarks of Stereotaxis, Inc. All other trademarks that appear in this report are the property of their respective owners.

1. Description of Business

Stereotaxis designs, manufactures and markets the Epoch Solution, which is an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency and efficacy for catheter-based, or interventional, procedures. The Epoch Solution is comprised of the Niobe ES Remote Magnetic Navigation System (“Niobe ES system”), Odyssey Information Management Solution (“Odyssey Solution”), and the Vdrive Robotic Navigation System (“Vdrive system”), and related devices.

The Niobe system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. As of June 30, 2017, the Company had an installed base of 128 Niobe ES systems.

In addition to the Niobe system and its components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation and training.

Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems.

We promote the full Epoch Solution in a typical hospital implementation, subject to regulatory approvals or clearances. The full Epoch Solution implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and software licenses. In hospitals where the full Epoch Solution has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

The core components of Stereotaxis systems, such as the Niobe system, Odyssey Solution, Cardiodrive and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union.

We have alliances with each of Biosense Webster, Inc., Philips Medical Systems, and Siemens AG Medical Solutions, through which we integrate our Niobe system with their respective digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of such alliances, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue indefinitely and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot assure as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

sufficient to support ongoing operations or expense reductions are in place. Accordingly, management has analyzed its planned operations to evaluate the Company’s ability to continue as a going concern. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of Niobe systems as well as by new placements of capital systems. The Company’s plans for improving its liquidity conditions, which are probable of effectively being implemented, primarily include its ability to control the timing and spending of its operating expenses and raising additional funds through capital transactions. Specifically, cash outflows for operating expenses could be reduced or delayed by transitioning certain cash payments to stock payments, by reducing project expenses, or by reducing headcount. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the six month period ended June 30, 2017 are not necessarily indicative of the results that may be expected for the year ended December 31, 2017 or for future operating periods.

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission (SEC) on March 16, 2017.

Financial Instruments

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

The Company measures certain financial assets and liabilities, including warrants, at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). See Note 11 for additional details.

Revenue and Costs of Revenue

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

ASC 605-25 permits management to estimate the selling price of undelivered components of a bundled sale for which it is unable to establish vendor-specific objective evidence (“VSOE”) or third-party evidence (“TPE”). This requires management to record revenue for certain elements of a transaction even though it might not have delivered other elements of the transaction, for which it was unable to meet the requirements for establishing VSOE or TPE. The Company believes that the guidance significantly improves the reporting of these types of transactions to more closely reflect the underlying economic circumstances. This guidance also prohibits the use of the residual method for allocating revenue to the various elements of a transaction and requires that the revenue be allocated proportionally based on the relative estimated selling prices.

Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future.

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

Share-Based Compensation

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

Net Earnings (Loss) per Common Share (“EPS”)

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. We apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

The following table sets forth the computation of basic and diluted EPS:


	Three months ended June 30,						Six months ended June 30,
	2017			2016			2017			2016
Net income (loss)	$	(177,299	)	$	(2,333,116	)	$	999,669		$	(4,607,417	)
Cumulative dividend on convertible preferred stock		(369,661	)		—			(732,849	)		—
Net income attributable to convertible preferred stock		—			—			(167,539	)		—

Earnings (net loss) attributable to common stockholders	$	(546,960	)	$	(2,333,116	)	$	99,281		$	(4,607,417	)

Shares used for basic EPS-weighted average shares		22,581,330			21,793,583			22,450,392			21,702,597
Effect of dilutive securities:		—			—			—			—
Restricted Stock Units		—			—			8,087			—
Stock Options, Appreciation Rights and Warrants		—			—			—			—
Weighted average shares used in computing earnings (net loss) per share		22,581,330			21,793,583			22,458,479			21,702,597
Basic EPS	$	(0.02	)	$	(0.11	)	$	0.00		$	(0.21	)
Diluted EPS	$	(0.02	)	$	(0.11	)	$	0.00		$	(0.21	)

The following potential common shares were excluded from diluted EPS for the six months ended June 30, 2017 as they were antidilutive: 645,885 stock options and stock appreciation rights, 628,775 restricted stock units, and 38,779,119 warrants.

In addition, the Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights or warrants in the calculation of diluted loss per common share for the three months ended June 30, 2017 or the three and six months ended June 30, 2016 because all such securities are anti-dilutive for the period. The Company had no unearned restricted shares during either period.

As of June 30, 2017, the Company had 645,885 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $7.01 per share, 38,779,119 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.82 per share, 38,463,078 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends at an exercise price of $0.65 per share, and 636,862 shares of unvested restricted share units.

Recently Issued Accounting Pronouncements

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” or “Update”) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” This amendment is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. This update is effective for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company) and interim periods within those fiscal years, with earlier application permitted. The Company adopted this guidance in the first quarter of 2017. The adoption of ASU 2016-09 did not materially impact the Company’s consolidated financial position, results of operations, equity or cash flows.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” regarding the subsequent measurement of inventory as part of its Simplification Initiative. This standard is effective for public companies for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company), including interim periods within those fiscal years. This Update should be applied prospectively, and early application is permitted as of the beginning of an interim or annual reporting period. The Company adopted this accounting standard update in the first quarter of 2017. The adoption of ASU 2015-11 did not materially impact the company’s results of operations, financial conditions, cash flows, or financial statement presentation.

In February 2016, the FASB issued ASU 2016-02, “Leases (ASC 842),” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840 Leases. The standard is effective for interim and annual periods beginning after December 31, 2018 (January 1, 2019 for the Company), with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update.

In August 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-15, to communicate amendments to FASB Account Standards Codification Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The ASU requires management to evaluate relevant conditions, events and certain management plans that are known or reasonably knowable as of the evaluation date when determining whether substantial doubt about an entity’s ability to continue as a going concern exists. Management will be required to make this evaluation for both annual and interim reporting periods. Management will have to make certain disclosures if it concludes that substantial doubt exists or when it plans to alleviate substantial doubt about the entity’s ability to continue as a going concern. The standard is effective for annual periods ending after December 15, 2016 and for interim reporting periods starting in the first quarter of 2017 (December 31, 2016 for the Company). Early adoption is permitted. The Company adopted this accounting standard update effective December 31, 2016 and provided the relevant disclosures in Note 1.

modified retrospective method that will result in a cumulative effect adjustment as of the date of adoption. Upon initial evaluation, management does not anticipate a significant change to its existing units of accounting which include systems, disposables and other accessories, royalty and other recurring revenue. The Company continues to evaluate other areas of the standard and its effect on the Company’s financial statements.

3. Inventories

Inventories consist of the following:


	June 30, 2017			December 31, 2016
Raw materials	$	2,435,855		$	2,397,430
Work in process		403,863			341,125
Finished goods		2,502,343			2,915,162
Reserve for obsolescence		(357,946	)		(272,614	)

Total inventory	$	4,984,115		$	5,381,103

4. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:


	June 30, 2017			December 31, 2016
Prepaid expenses	$	328,404		$	575,886
Deferred financing costs		75,068			24,658
Deposits		254,987			293,992

Total prepaid expenses and other assets		658,459			894,536
Less: Noncurrent prepaid expenses and other assets		(41,047	)		(39,241	)

Total current prepaid expenses and other assets	$	617,412		$	855,295

5. Property and Equipment

Property and equipment consist of the following:


	June 30, 2017			December 31, 2016
Equipment	$	7,258,587		$	8,397,528
Equipment held for lease		0			303,412
Leasehold improvements		2,592,338			2,719,860

		9,850,925			11,420,800
Less: Accumulated depreciation		(9,058,558	)		(10,334,556	)

Net property and equipment	$	792,367		$	1,086,244

6. Intangible Assets

As of June 30, 2017, the Company had total intangible assets of $3,221,069. Accumulated amortization at June 30, 2017, was $2,884,161.

7. Accrued Liabilities

Accrued liabilities consist of the following:


	June 30,			December 31,
	2017			2016
Accrued salaries, bonus, and benefits	$	2,197,612		$	2,452,183
Accrued rent		640,496			965,412
Accrued licenses and maintenance fees		573,378			561,450
Accrued warranties		181,308			222,845
Accrued taxes		267,164			219,017
Accrued professional services		112,500			180,450
Other		236,369			210,216

Total accrued liabilities		4,208,827			4,811,573
Less: Long term accrued liabilities		(321,316	)		(320,409	)

Total current accrued liabilities	$	3,887,511		$	4,491,164

Our primary company facilities are located in St. Louis, Missouri where we currently lease approximately 52,000 square feet of office and 12,000 square feet of demonstration and assembly space. In the third quarter of 2013, the Company modified the existing lease agreement to terminate approximately 13,000 square feet of unimproved space. The costs associated with the termination were $515,138 and were accrued as a rent liability as of September 30, 2013. As of June 30, 2017, the remaining accrued costs associated with the termination were $138,528.

In the fourth quarter of 2015, the Company entered an agreement to sublease 3,152 square feet of the first floor office space through December 31, 2018. In July 2016, the Company and the subtenant mutually agreed to an early termination of the sublease, effective July 31, 2016.

In August 2016 the Company entered into an agreement to sublease approximately 11,000 square feet of office space through December 31, 2018. The costs associated with the sublease were $40,972 and were accrued as a rent liability as of August 31, 2016. In January 2017, as part of the sublease agreement, the Company subleased an additional 16,000 square feet through December 31, 2018. The costs associated with the January sublease were $28,208. As of June 30, 2017, the remaining accrued costs associated with the termination were $38,633.

8. Deferred Revenue

Deferred revenue consists of the following:


	June 30,			December 31,
	2017			2016
Product shipped, revenue deferred	$	665,726		$	549,709
Customer deposits		1,455,000			2,910,000
Deferred service and license fees		6,358,017			5,813,956

Total deferred revenue		8,478,743			9,273,665
Less: Long-term deferred revenue		(377,076	)		(522,329	)

Total current deferred revenue	$	8,101,667		$	8,751,336

9. Long-Term Debt and Credit Facilities

Revolving Line of Credit

The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $10.0 million subject to the value of collateralized assets. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender. The facility was amended on March 27, 2015, extending the maturity date to March 31, 2018 and on May 10, 2016, the Company and the primary lender agreed to modify certain financial covenants. The amended agreement requires the Company to maintain a liquidity ratio greater than 1.50:1.00, excluding certain short term advances from the calculation, and a minimum tangible net worth of not less than (no worse than) negative $24.0 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, and September 30, 2017; and not less than (no worse than) negative $24.5 million for the quarters ended December 31, 2017 and March 31, 2018. As of June 30, the Company is in compliance with its loan covenants.

As of June 30, 2017, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit are made based on the borrowing capacity one week in arrears. As of June 30, 2017, the Company had a borrowing capacity of $3.9 million based on the Company’s collateralized assets. The Company’s total liquidity as of June 30, 2017, was $8.9 million which included cash and cash equivalents of $5.0 million.

Healthcare Royalty Partners Debt

In November 2011, the Company entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed $15 million from Healthcare Royalty Partners. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the nine months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012. The loan was to be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis’ Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners was entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan was repaid. The loan was a full recourse loan, scheduled to mature on December 31, 2018, and included interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement were insufficient to pay all amounts of interest due on the loan, then such deficiency would have increased the outstanding principal amount on the loan. The loan was also secured by certain assets and intellectual property of the Company. The agreement also contained customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender.

In September 2016, the Company extinguished the remainder of the debt of $18.1 million, net of deferred financing costs of approximately $0.3 million, as well as accrued interest of $0.5 million for $13.0 million based upon an agreement entered into with Healthcare Royalty Partners. Following the repayment of the loan obligation, the royalties under the Biosense Agreement are now paid to the Company. As a result of the debt extinguishment, the Company recognized a net gain of $5.6 million in 2016.

10. Convertible Preferred Stock and Stockholders’ Equity

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of June 30, 2017.

Convertible Preferred Stock and Warrants

On September 26, 2016, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors whereby it agreed to sell, for an aggregate purchase price of $24.0 million, (i) an aggregate of 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The transaction closed on September 29, 2016.

The Company received net proceeds from the sale of the convertible preferred stock and warrants of $23.0 million, after offering expenses. The Company used $13.0 million of the funds to satisfy in full all amounts outstanding under the Loan Agreement with Healthcare Royalty Partners, as noted above, and anticipates using the remaining proceeds for general corporate purposes.

The designations, preferences, powers and rights of the convertible preferred shares are set forth in a Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (“Certificate of Designations”) filed with the Delaware Secretary of State. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Instead the value of the accrued dividends is added to the liquidation preference of the convertible preferred shares and will increase the number of shares of common stock issuable upon conversion. Each convertible preferred share is convertible at the option of the holder from and after the date of issuance with no expiration date, at an initial conversion price of $0.65 per share, subject to adjustment in the event of stock splits, dividends, mergers, sales of all or substantially all of our assets or similar transactions, subject to specified beneficial ownership issuance limitations. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a change of control as defined in the Certificate of Designations.

The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution and winding up of the Company. No such distributions or payments upon the liquidation, dissolution and winding up of the Company may be made to the holders of common stock unless and until the holders of convertible preferred shares have received the stated value of $1,000 per share plus any accrued and unpaid dividends. Until all convertible preferred shares have been converted or redeemed, no dividends may be paid on the common stock without the express written consent of the holders of a majority of the outstanding convertible preferred shares. In the event that dividends or other distributions of assets are made or paid by the Company to the holders of the common stock, the holders of convertible preferred shares are entitled to participate in such dividend or distribution on an as-converted basis.

On the date of the issuance, the fair value of the convertible preferred stock was greater than the allocated proceeds received for the Series A Convertible Preferred Stock. As such, the Company accounted for the beneficial conversion feature under ASC 470-20, Debt with Conversion feature under ASC 470-20, Debt with Conversion and Other Options. The Company recorded a deemed dividend charge of $6.1 million for the accretion of a discount on the Series A Convertible Preferred Stock. The deemed dividend was a non-cash transaction and was reflected below net loss to arrive at net loss available to common stockholders in 2016. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

The warrants issued in conjunction with the convertible preferred stock have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants may be exercised by any holder on a cashless basis if, at any time after the date that is 180 days after the closing, the registration statement required by the Registration Rights Agreement is not effective and available for resale of all of the shares of common stock issuable upon exercise of such holder’s warrants. Due to the fact that the warrants are puttable upon the occurrence of certain events outside of the Company’s control, the warrants qualify as liabilities under ASC 480-10. The calculated fair value of the warrants is classified as a liability and is periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations. See Note 11 for additional details.

On December 2, 2016, 100 shares of convertible preferred stock plus accumulated dividends were converted into 155,439 common shares.

Listing Transfer to OTCQX® Best Market

On August 2, 2016, the Company received a determination letter from the Nasdaq Hearings Panel (the “Panel”) notifying the Company that its common stock would be delisted from The Nasdaq Capital Market (“Nasdaq”) and that suspension of trading in the shares would be effective at the open of business on August 4, 2016. The delisting was completed by the filing of a Form 25 Notification of Delisting with the Securities Exchange Commission by Nasdaq on November 10, 2016. The Panel made the determination to delist the Company’s common stock because the Company did not demonstrate compliance with the minimum $35 million market value of listed securities requirement for a period of ten consecutive trading days by August 1, 2016, as required by a decision previously issued by the Panel on May 2, 2016. The Company’s shares of common stock commenced trading on the OTCQX^® Best Market on August 4, 2016 under the Company’s current ticker symbol of “STXS.”

Controlled Equity Offering

The Company entered into a Controlled Equity Offering^SM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company paid Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement.

There were no proceeds from the Controlled Equity Offering during the twelve months ended December 31, 2016. The Sales Agreement expired in November 2016 upon the expiration of our Registration Statement on Form S-3.

Stock Award Plans

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At June 30, 2017, the Company had 5,544,098 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

At June 30, 2017, the total compensation cost related to options, stock appreciation rights and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $0.9 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

A summary of the option and stock appreciation rights activity for the six month period ended June 30, 2017 is as follows:


	Number of Options/SARs			Range of Exercise Price		Weighted Average Exercise Price per Share
Outstanding, December 31, 2016		671,887		$	1.45 - $116.40	$	8.77
Granted		10,000		$	0.62	$	0.62
Exercised		—			—		—
Forfeited		(36,002	)	$	2.15 - $116.40	$	38.16

Outstanding, June 30, 2017		645,885		$	0.62 - $54.90	$	7.01

A summary of the restricted stock unit activity for the six month period ended June 30, 2017 is as follows:


	Number of Restricted Stock Units			Weighted Average Grant Date Fair Value per Unit
Outstanding, December 31, 2016		1,167,099		$	1.48
Granted		30,000		$	0.68
Vested		(515,737	)	$	1.76
Forfeited		(44,500	)	$	1.51

Outstanding, June 30, 2017		636,862		$	1.21

11. Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and warrants. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below:

Level 1:

Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2:

Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3:

Values are generated from model-based techniques that use significant assumptions not observable in the market.

The following table sets forth the Company’s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy. As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.


	Fair Value Measurement Using
	Total		Quoted Prices in Active Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets at June 30, 2017:
Cash equivalents	$	791		791		—		—

Total assets at fair value	$	—		—		—		—

Liabilities at June 30, 2017:
Warrants issued May 2012	$	1,819		—		—		1,819
Warrants issued August 2013		35,625		—		—		35,625
Warrants issued September 2016		16,320,000		—		—		16,320,000

Total liabilities at fair value:	$	16,357,444		—		—		16,357,444

Assets at December 31, 2016:
Cash equivalents	$	—		—		—		—

Total assets at fair value	$	—		—		—		—

Liabilities at December 31, 2016:
Warrants issued May 2012	$	66,081		—		—		66,081
Warrants issued August 2013		151,695		—		—		151,695
Warrants issued September 2016		19,569,231		—		—		19,569,231

Total liabilities at fair value:	$	19,787,007		—		—		19,787,007

Level 1

The Company’s financial assets consist of cash equivalents invested in money market funds in the amount of $791 and $0 at June 30, 2017 and December 31, 2016, respectively. These assets are classified as Level 1 as described above and total interest income recorded for these investments was insignificant during both the six month periods ended June 30, 2017, and June 30, 2016. There were no transfers in or out of Level 1 during the period ended June 30, 2017.

Level 2

The Company does not have any financial assets or liabilities classified as Level 2.

Level 3

In conjunction with the Company’s May 2012, August 2013 and September 2016 financing transactions, the Company issued warrants to purchase shares of the Company’s common stock. Due to the provisions included in the warrant agreements, the warrants did not meet the exemptions for equity classification and as such, the Company accounts for these warrants as derivative instruments. The calculated fair value of the warrants is classified as a liability and is periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

The remaining warrants from the May 2012 transaction (PIPE Warrants) expire in May 2018 and were revalued as of June 30, 2017 using the following assumptions: 1) volatility of 79.92%; 2) risk-free interest rate of 1.24%; and 3) a closing stock price of $0.58.

The remaining warrants from the August 2013 transaction (Exchange Warrants) expire in November 2018 and were revalued as of June 30, 2017 using the following assumptions: 1) volatility of 92.83%; 2) risk-free interest rate of 1.24%; and 3) a closing stock price of $0.58.

The remaining warrants from the September 2016 transaction expire in September 2021 and were valued as of June 30, 2017 using the following assumptions: 1) volatility of 117.82%; 2) risk-free interest rate of 1.89%; and 3) a closing stock price of $0.58.

The significant unobservable input used in the fair value measurement of the Company’s warrants is volatility. Significant increases (decreases) in the volatility in isolation would result in significantly higher (lower) liability fair value measurements.

The following table sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the six month period ended June 30, 2017:


	Warrants issued May 2012			Warrants issued August 2013			Warrants issued September 2016			Total Liabilities
Balance at beginning of period	$	66,081		$	151,695		$	19,569,231		$	19,787,007
Issues		—			—			—			—
Settlements		—			—			—			—
Revaluation		(64,262	)		(116,070	)		(3,249,231	)		(3,429,563	)

Balance at end of period	$	1,819		$	35,625		$	16,320,000		$	16,357,444

The Company currently does not have derivative instruments to manage its exposure to currency fluctuations or other business risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. All derivative financial instruments are recognized in the balance sheet at fair value.

12. Product Warranty Provisions

The Company’s standard policy is to warrant all Niobe, Odyssey, and Vdrive systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

Accrued warranty, which is included in other accrued liabilities, consists of the following:


	June 30, 2017			December 31, 2016
Warranty accrual, beginning of the fiscal period	$	222,845		$	316,835
Accrual adjustment for product warranty		35,228			103,743
Payments made		(76,765	)		(197,733	)

Warranty accrual, end of the fiscal period	$	181,308		$	222,845

13. Commitments and Contingencies

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

14. Subsequent Events

None.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our financial statements and notes thereto included in this report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2016. Operating results are not necessarily indicative of results that may occur in future periods.

This report includes various forward-looking statements that are subject to risks and uncertainties, many of which are beyond our control. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in “Item 1A. Risk Factors.” Forward-looking statements discuss matters that are not historical facts. Forward-looking statements include, but are not limited to, discussions regarding our operating strategy, sales and marketing strategy, regulatory strategy, industry, economic conditions, financial condition, liquidity, capital resources, and results of operations. Such statements include, but are not limited to, statements preceded by, followed by, or that otherwise include the words “believe”, “expects”, “anticipates”, “intends”, “estimates”, “projects”, “can”, “could”, “may”, “would”, or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should not unduly rely on these forward-looking statements, which speak only as of the date on which they are made. They give our expectations regarding the future, but are not guarantees. We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

Overview

Stereotaxis designs, manufactures and markets the Epoch Solution, which is an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The Epoch Solution is comprised of the Niobe ES robotic system, Odyssey Solution, and the Vdrive system. We believe that the Epoch Solution represents a revolutionary technology in the interventional surgical suite, or “interventional lab,” and has the potential to become the standard of care for a broad range of complex cardiology procedures. We also believe that our technology represents an important advance in the ongoing trend toward digital instrumentation in the interventional lab and provides substantial, clinically important improvements and cost efficiencies over manual interventional methods, which require years of physician training and often result in long and unpredictable procedure times and sub-optimal therapeutic outcomes.

The Niobe ES system is the latest generation of the Niobe Remote Magnetic Navigation System (“Niobe system”). This system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. The core components of the Niobe system have received regulatory clearance in the U.S., Canada, Europe, China, Japan and various other countries. As of June 30, 2017, the Company had an installed base of 128 Niobe ES systems.

Stereotaxis also has developed the Odyssey Solution which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation and training. The Odyssey Solution may be acquired in conjunction with a Niobe system or on a stand-alone basis for installation in interventional labs and other locations where clinicians often desire the benefits of the Odyssey Solution that we believe can improve clinical workflows and related efficiencies.

We generate revenue from both the initial capital sales of the Niobe, Odyssey and Vdrive systems as well as recurring revenue from the sale of our proprietary disposable devices, from ongoing license and service contracts, and from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters.

commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue indefinitely and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot assure as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

The Company believes the cash on hand at June 30, 2017 and expected borrowing capacity available will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. This evaluation assumes the Company is able to renew and has the ability to borrow under its asset based revolving credit facility which matures on March 31, 2018. The Company expects to be able to renew this facility at similar terms, as it has successfully done so in the past. There is no assurance that the revolving credit facility will be renewed in a timely manner, in amounts that are sufficient to meet the Company’s obligations as they become due, or on terms acceptable to the Company, or at all. The Company has sustained operating losses throughout its corporate history and expects that its 2017 expenses will exceed its 2017 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. Accordingly, management has analyzed its planned operations to evaluate the Company’s ability to continue as a going concern. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of Niobe systems as well as by new placements of capital systems. The Company’s plans for improving its liquidity conditions, which are probable of effectively being implemented, primarily include its ability to control the timing and spending of its operating expenses and raising additional funds through capital transactions. Specifically, cash outflows for operating expenses could be reduced or delayed by transitioning certain cash payments to stock payments, by reducing project expenses, or by reducing headcount. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. We review our estimates and judgments on an on-going basis. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We believe the following accounting policies are critical to the judgments and estimates we use in preparing our financial statements. For a complete listing of our critical accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2016.

Revenue Recognition

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

Results of Operations

Comparison of the Three Months Ended June 30, 2017 and 2016

Revenue. Revenue increased from $7.9 million for the three months ended June 30, 2016 to $8.5 million for the three months ended June 30, 2017, an increase of 8%. Revenue from the sale of systems increased from $0.9 million to $1.8 million, an increase of approximately 95%, primarily due to increased sales volumes. We recognized revenue on one Niobe system and a total of $0.8 million for Odyssey systems during the 2017 period. System revenue for the prior period included $0.3 million for Niobe system installations, $0.5 million for Odyssey and Odyssey Cinema systems, and $0.1 million for Vdrive system installations. Revenue from sales of disposable interventional devices, service and accessories decreased to $6.6 million for the three months ended June 30, 2017 from $6.9 million for the three months ended June 30, 2016, a decrease of approximately 4% due to lower disposable unit sales.

Cost of Revenue. Cost of revenue increased to $2.2 million for the three months ended June 30, 2017 from $1.1 million for the three months ended June 30, 2016. As a percentage of our total revenue, overall gross margin decreased to 74% for the three months ended June 30, 2017 from 86% for the three months ended June 30, 2016. Cost of revenue for systems sold increased from $0.4 million for the three months ended June 30, 2016 to $0.9 million for the three months ended June 30, 2017. Gross margin for systems decreased to 50% for the three months ended June 30, 2017 from 58% for the three months ended June 30, 2016 due to lower margins within the Odyssey product line. Cost of revenue for disposables, service, and accessories increased to $1.3 million for the three months ended June 30, 2017 from $0.7 million for the three months ended June 30, 2016, driven by higher expenses incurred under service contracts in the current year period. Gross margin for disposables, service, and accessories was 81% for the current quarter compared to 90% for the three months ended June 30, 2016.

Research and Development Expenses. Research and development expenses decreased from $1.4 million for the three months ended June 30, 2016 to $1.3 million for the three months ended June 30, 2017, a decrease of approximately 10%. This decrease was primarily due to lower headcount costs.

Sales and Marketing Expenses. Sales and marketing expenses decreased from $4.2 million for the three months ended June 30, 2016 to $3.5 million for the three months ended June 30, 2017, a decrease of approximately 18%. This decrease was primarily due to lower headcount costs and related travel expenses.

General and Administrative Expenses. General and administrative expenses include regulatory, clinical, finance, information systems, legal, general management and routine training expenses. General and administrative expenses decreased from $2.8 million for the three months ended June 30, 2016 to $1.9 million for the three months ended June 30, 2017, a decrease of approximately 30%. This decrease was primarily driven by lower headcounts costs and administrative costs.

Other Income (Expense). Other income (expense) represents the non-cash change in market value of certain warrants classified as a derivative and recorded as a current liability under general accounting principles for determining whether an instrument (or embedded feature) is indexed to an entity’s own stock.

Interest Expense. Interest expense decreased from $0.8 million for the three months ended June 30, 2016 to less than $0.1 million for the three months ended June 30, 2017 due to the extinguishment of the Healthcare Royalty Partners debt.

Comparison of the Six Months Ended June 30, 2017 and 2016

Revenue. Revenue decreased from $16.5 million for the six months ended June 30, 2016 to $15.4 million for the six months ended June 30, 2017, a decrease of approximately 7%. Revenue from the sale of systems decreased from $3.0 million to $2.0 million, a decrease of approximately 32%, primarily due to lower Niobe installation revenue and decreased sales volumes in the Odyssey product line. We recognized revenue on one Niobe system, and a total of $1.0 million on Odyssey and Odyssey Cinema systems during the 2017 period. System revenue for the prior year period included revenue on one Niobe system, a total of $1.4 million on Odyssey and Odyssey Cinema systems, and a total of $0.1 million on Vdrive system installations. Revenue from sales of disposable interventional devices, service and accessories decreased to $13.4 million for the six months ended June 30, 2017 from $13.5 million for the six months ended June 30, 2016, a decrease of approximately 1%.

Cost of Revenue. Cost of revenue increased from $3.3 million for the six months ended June 30, 2016 to $3.5 million for the six

months ended June 30, 2017, an increase of approximately 6%. As a percentage of our total revenue, overall gross margin decreased to 78% for the six months ended June 30, 2017 compared to 80% during the same six month period of the prior year due to change in product mix and higher costs incurred on service contracts in the current year period. Cost of revenue for systems sold decreased from $1.5 million for the six months ended June 30, 2016 to $1.1 million for the six months ended June 30, 2017, a decrease of approximately 23%, primarily due to decreased system sales volumes and installations across all product lines. Gross margin for systems decreased from 51% for the six months ended June 30, 2016 to 44% for the six months ended June 30, 2017 due to lower margins within the Odyssey product line. Cost of revenue for disposables, service and accessories increased to $2.3 million during the 2017 period from $1.8 million during the 2016 period, resulting in a decrease in gross margin to 83% from 87% between these periods driven by higher expenses incurred under service contracts in the current year period.

Research and Development Expenses. Research and development expenses decreased from $2.9 million for the six months ended June 30, 2016 to $2.4 million for the six months ended June 30, 2017, a decrease of approximately 16%. This decrease was due to lower headcount costs, reduced project based expenses, and lower rent.

Sales and Marketing Expenses. Sales and marketing expenses decreased from $8.1 million for the six months ended June 30, 2016 to $7.1 million for the six months ended June 30, 2017, a decrease of approximately 12%. This decrease was due to lower headcount and reduced rent.

General and Administrative Expenses. General and administrative expenses include regulatory, clinical, finance, information systems, legal, general management and training expenses. General and administrative expenses decreased to $4.8 million for the six months ended June 30, 2017 from $5.4 million for the six months ended June 30, 2016, a decrease of 11%. This decrease was primarily driven by lower headcount costs and lower expense for consulting, administrative and rent.

Other Income. Other income represents the change in market value of certain warrants classified as a derivative and recorded as a current liability under general accounting principles for determining whether an instrument (or embedded feature) is indexed to an entity’s own stock. The primary drivers of fluctuations in this balance are changes in the Company’s stock price from one period to the next.

Interest Expense. Interest expense decreased from $1.6 million for the six months ended June 30, 2016 to $0.1 million for the six months ended June 30, 2017 due to the extinguishment of the Healthcare Royalty Partners debt.

Liquidity and Capital Resources

Liquidity refers to the liquid financial assets available to fund our business operations and pay for near-term obligations. These liquid financial assets consist of cash and cash equivalents. At June 30, 2017 we had $5.0 million of cash and equivalents. We had working capital deficits of $14.6 million and $16.2 million as of June 30, 2017 and December 31, 2016, respectively. The decrease in the working capital deficit was primarily driven by the revaluation of the warrants issued with the convertible preferred stock transaction, partially offset by the first half operating loss. At June 30, 2017 these and other warrants were recorded as a current liability in the amount of $16.4 million as compared to $19.8 million as of December 31, 2016. See Footnote 11 for additional details.

The following table summarizes our cash flow by operating, investing and financing activities for the six months ended June 30, 2017 and 2016 (in thousands):


	Six Months Ended June 30,
	2017			2016
Cash flow used in operating activities	$	(3,381	)	$	(4,609	)
Cash flow used in investing activities		(4	)		—
Cash flow provided by (used in) financing activities		(81	)		2,874

Net cash used in operating activities. We used approximately $3.4 million and $4.6 million of cash for operating activities during the six months ended June 30, 2017 and 2016, respectively. The decrease in cash used in operating activities was driven by reduced operating losses and interest expense partially offset by changes in working capital.

Net cash used in investing activities. We used approximately $4,000 of cash during the six month period ended June 30, 2017 for the purchases of equipment, and there were no purchases of equipment for the six month period ended June 30, 2016.

Net cash provided by (used in) financing activities. We used approximately $81,000 of cash for the six month periods ended June 30, 2017, compared to approximately $2.9 million generated for the six month period ended June 30, 2016. The cash used for the

six months ended June 30, 2017 was driven by payments of deferred financing costs. The cash generated for the six months ended June 30, 2016 was primarily driven by borrowings against our revolving line of credit.

The Company believes the cash on hand at June 30, 2017 and expected borrowing capacity available will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. This evaluation assumes the Company is able to renew and borrow under its asset based revolving credit facility which matures on March 31, 2018. The Company expects to be able to renew this facility at similar terms, as it has successfully done so in the past. There is no assurance that the revolving credit facility will be renewed in a timely manner, in amounts that are sufficient to meet the Company’s obligations as they become due, or on terms acceptable to the Company, or at all. The Company has sustained operating losses throughout its corporate history and expects that its 2017 expenses will exceed its 2017 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of Niobe systems as well as by new placements of capital systems. The Company’s plans for improving its liquidity conditions, which are probable of effectively being implemented, primarily include its ability to control the timing and spending of its operating expenses and raising additional funds through capital transactions. Specifically, cash outflows for operating expenses could be reduced or delayed by transitioning certain cash payments to stock payments, by reducing project expenses, or by reducing headcount. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

Until we can generate significant cash flow from our operations, we expect to continue to fund our operations with cash resources primarily generated from the proceeds of our past and future public offerings, private sales of our equity securities and working capital and equipment financing loans. In the future, we may finance cash needs through the sale of other equity securities or non-core assets, strategic collaboration agreements, debt financings or through distribution rights. We cannot assure you that such additional financing will be available on a timely basis on terms acceptable to us or at all, that we will be able to engage in equity financings because our common stock is no longer listed on a national securities exchange, or that such financing will not be dilutive to our stockholders. If adequate funds are not available to us, we could be required to delay development or commercialization of new products, to license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize ourselves or to reduce the sales, marketing, customer support or other resources devoted to our products, any of which could have a material adverse effect on our business, financial condition and results of operations. In addition, we could be required to cease operations.

Capital Resources

As of June 30, 2017, our borrowing facilities were comprised of a revolving line of credit maintained with our primary lender, Silicon Valley Bank.

Revolving Line of Credit

The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $10.0 million subject to the value of collateralized assets. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender. The facility was amended on March 27, 2015, extending the maturity date to March 31, 2018 and on May 10, 2016, the Company and the primary lender agreed to modify certain financial covenants. The amended agreement requires the Company to maintain a liquidity ratio greater than 1.50:1.00, excluding certain short term advances from the calculation, and a minimum tangible net worth of not less than (no worse than) negative $24.0 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, and September 30, 2017; and not less than (no worse than) negative $24.5 million for the quarters ended December 31, 2017 and March 31, 2018. As of June 30, 2017, the Company is in compliance with its loan covenants.

Healthcare Royalty Partners Debt

In November 2011, we entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed $15 million from Healthcare Royalty Partners. The Company was permitted to borrow up to an additional $5 million in the

aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the nine months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012. The loan was to be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis’ Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners was entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan was repaid. The loan was a full recourse loan, scheduled to mature on December 31, 2018, and included interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement were insufficient to pay all amounts of interest due on the loan, then such deficiency would have increased the outstanding principal amount on the loan. The loan was also secured by certain assets and intellectual property of the Company. The agreement also contained customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender.

Common Stock

Convertible Preferred Stock and Warrants

outstanding convertible preferred shares. In the event that dividends or other distributions of assets are made or paid by the Company to the holders of the common stock, the holders of convertible preferred shares are entitled to participate in such dividend or distribution on an as-converted basis.

Controlled Equity Offering

Off-Balance Sheet Arrangements

We do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity, market or credit risk that could have arisen if we had engaged in these relationships.

ITEM 3.

[RESERVED]

None.

ITEM 4.

CONTROLS AND PROCEDURES

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

Changes In Internal Control Over Financial Reporting: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, also conducted an evaluation of the Company’s internal control over financial reporting to determine whether any changes occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the period covered by this report.

PART II – OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

We are involved from time to time in various lawsuits and claims arising in the normal course of business. Although the outcomes of these lawsuits and claims are uncertain, we do not believe any of them will have a material adverse effect on our business, financial condition or results of operations.

ITEM 1A.

RISK FACTORS

Additional Risk Factors are discussed in our Annual Report on Form 10-K for the year ended December 31, 2016.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

[RESERVED]

None.

ITEM 5.

OTHER INFORMATION

None.

ITEM 6.

EXHIBITS

Exhibits: See Exhibit Index herein

STEREOTAXIS, INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 10, 2017

By:

/s/ Martin C. Stammer

Martin C. Stammer

Chief Financial Officer

EXHIBIT INDEX


Number		Description

3.1		Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q (file No. 000-50884) for the fiscal quarter ended September 30, 2004.

3.2		Certificate of Amendment to Amended and Restated Certificate of Incorporation, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 000-50884) filed on July 10, 2012.

3.3		Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K (file No. 001-36159) filed on September 30, 2016.

3.4		Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.

10.1		Amended and Restated Stereotaxis, Inc. 2012 Stock Incentive Plan, as adopted February 22, 2017, filed herewith.

31.1		Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).

31.2		Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).

32.1		Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).

32.2		Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema Document.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		XBRL Taxonomy Extension Label Linkbase Document.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

EX-10.1 2 d439571dex101.htm EX-10.1 EX-10.1

EXHIBIT 10.1

STEREOTAXIS, INC.

2012 STOCK INCENTIVE PLAN

As amended and restated effective February 22, 2017

1. Purpose of the Plan.

The purpose of the Plan is to provide the Company with a means to assist in recruiting, retaining, and rewarding certain employees, directors, consultants, and other individuals providing services to the Company and to motivate such individuals to exert their best efforts on behalf of the Company by providing incentives through the granting of Awards. By granting Awards to such individuals, the Company expects that the interests of the recipients will be better aligned with those of the Company by providing recipients with a proprietary interest in the growth and performance of the Company.

2. Definitions. Unless the context clearly indicates otherwise, the following capitalized terms shall have the meanings set forth below:

A. “Act” means the Securities Exchange Act of 1934, as amended, or any successor thereto.

B. “Award” means a grant under the Plan of an Option, Stock Appreciation Right, Cash-Based Award or Other Stock-Based Award.

C. “Award Agreement” means the document (in written or electronic form) communicating the terms, conditions and limitations applicable to an Award. The Committee may, in its discretion, require that the Participant execute such Award Agreement, or may provide for procedures through which Award Agreements are made available but not executed. Any Participant who is granted an Award and who does not affirmatively reject the applicable Award Agreement shall be deemed to have accepted the terms of Award as embodied in the Award Agreement.

D. “Board” means the Board of Directors of the Company.

E. “Cash-Based Award” means an Award described in Section 7 as a Cash-Based Award.

F. “Change of Control” means the occurrence of one or more of the following:

(1) The purchase or other acquisition (other than from the Company) by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Act (excluding, for this purpose, the Company or its subsidiaries or any employee benefit plan of the Company or its subsidiaries), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of 35% or more of either the then-outstanding shares of common stock of the Company or the combined voting power of the Company’s then-outstanding voting securities entitled to vote generally in the election of directors;

(2) Individuals who, as of the date hereof, constitute the Board (as of the date hereof, the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board, provided that any person who becomes a director subsequent to the date hereof whose election, or

nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (other than an individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Act) shall be, for purposes of this section, considered as though such person were a member of the Incumbent Board; or

(3) The consummation of a reorganization, merger or consolidation, in each case with respect to which persons who were the stockholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than 50% of, respectively, the common stock and the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated corporation’s then-outstanding voting securities, or of a liquidation or dissolution of the Company or of the sale of all or substantially all of the assets of the Company.

Notwithstanding the foregoing, a Change of Control shall not be deemed to have occurred with respect to any Award that (i) provides “non-qualified deferred compensation” within the meaning of Code Section 409A and (ii) settles upon a Change of Control, unless such foregoing event constitutes a “change in ownership” of the Company, a “change in effective control” of the Company, or a “change in the ownership of a substantial portion of the assets” of the Company in each case, as defined under Code Section 409A.

G. “Code” means the Internal Revenue Code of 1986, as amended, or any successor thereto, and the regulations and other guidance promulgated thereunder.

H. “Committee” means the Compensation Committee of the Board, and any successor committee thereto or such other committee of the Board as may be designated by the Board to administer this Plan in whole or in part including any subcommittee of the Board as designated by the Board.

I. “Company” means Stereotaxis, Inc., a Delaware corporation, and any successor thereto.

J. “Employer” means the Company and any other entity directly or indirectly controlling, controlled by, or under common control with, the Company or any other entity designated by the Board or the Committee in which the Company has an interest. The term “control” (including the terms “controlling”, “controlled by” and “under common control with”) has the meaning ascribed to it under Rule 405 of the Securities Act of 1933, as amended, or any successor thereto, and the regulations and other guidance promulgated thereunder.

K. “Fair Market Value” means the closing sale price, regular way, or, in case no such sale takes place on such date, the average of the closing bid and asked prices, regular way, on the date such Fair Market Value is measured of one share of Stock as reported in the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the Nasdaq Global Market or, if the shares of Stock are not listed or admitted to trading on the Nasdaq Global Market, as reported in the principal consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which the shares of Stock are listed or admitted to trading or, if the shares of Stock are not listed or admitted to trading on any national securities exchange, the last quoted sale price on such date or, if not so quoted, the average of the

high bid and low asked prices in the over-the-counter market on such date, as reported by the National Association of Securities Dealers, Inc. Automated Quotations System or such other system then in use. If shares of Stock are not publicly held or so listed or publicly traded, the Fair Market Value per share of Stock shall be 100% of the fair market value of a share of Stock on the date such Fair Market Value is measured, as determined in good faith by the Committee.

L. “Incentive Stock Option” means a stock option which is intended to be an incentive stock option within the meaning of Code Section 422.

M. “Non-Qualified Stock Option” means a stock option which is not an Incentive Stock Option.

N. “Option” means both an Incentive Stock Option and a Non-Qualified Stock Option.

O. “Other Stock-Based Award” means an Award granted pursuant to Section 7 and described as an Other Stock-Based Award.

P. “Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if, at the time of the granting of the Option, each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain, or such other meaning as may be hereafter ascribed to it in Code Section 424.

Q. “Participant” means any director or any employee of the Company, or any of its subsidiaries (including subsidiaries of subsidiaries), or any other entity in which the Company has a significant equity or other interest, as determined by the Committee, as well as any individual providing services to the Company who is selected to receive an Award; provided, that Incentive Stock Options may only be granted to employees of the Company or any of its Subsidiaries.

R. “Plan” means the Stereotaxis, Inc. 2012 Stock Incentive Plan.

S. “Stock” means the common stock, par value of $0.001 per share, of the Company.

T. “Stock Appreciation Right” means a stock appreciation right described in Section 6.

U. “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if, at the time of granting an Award, each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain, or such other meaning as may be hereafter ascribed to it in Code Section 424.

3. Stock Subject to the Plan.

As of the date of adoption of this Plan by the Board or the Committee, as applicable, the number of shares of Stock available for Awards under the Plan shall be eight million two hundred ninety thousand (8,290,000). The maximum number of shares of Stock subject to Awards which may be granted during a calendar year to a Participant shall be 1,000,000. The Company may, in its discretion, use shares of Stock held in the treasury in lieu of authorized but unissued shares of Stock.

If any Award shall expire or terminate or be cancelled or forfeited for any reason, the shares subject to the Award shall again be available for the purposes of the Plan. Any shares of Stock which are tendered by a Participant as full or partial payment to the Company to satisfy a purchase price related to an Award shall not be available for the purposes of the Plan. To the extent any shares subject to an Award are not delivered to a Participant because such shares are used to satisfy an applicable tax-withholding obligation or used to satisfy a purchase price related to an Option, such withheld shares shall not be available for the purposes of the Plan. Shares of Stock subject to the grant of a Stock Appreciation Right shall not become available again for issuance under this Plan upon exercise or settlement of such Stock Appreciation Right for a lesser number of shares. Awards that by their terms may only be settled in cash shall not reduce the number of shares available for purposes of the Plan, and if cash is issued in lieu of Stock pursuant to an Award, such shares will not become available again for issuance under this Plan.

All the shares of Stock available under the Plan may be used for the grant of Incentive Stock Options.

4. Administration.

The Plan shall be administered by the Committee. Subject to the express provisions of the Plan, the Committee shall have plenary authority, in its discretion, to determine the individuals to whom, and the time or times at which, Awards shall be granted and the number of shares, if applicable, to be subject to each Award. In making such determinations, the Committee may take into account the nature of services rendered by the respective individuals, their present and potential contributions to the Employer’s success and such other factors as the Committee, in its discretion, shall deem relevant. Subject to the express provisions of the Plan, the Committee shall also have plenary discretionary authority to interpret the Plan, to prescribe, amend and rescind rules and regulations relating to it, to determine the terms and provisions of the respective Award Agreements (which need not be identical) and to make all other determinations necessary or advisable for the administration of the Plan. The Committee’s determinations on the matters referred to in this Section 4 shall be conclusive.

Notwithstanding the foregoing, the Committee may not amend the terms of outstanding Award Agreements without the approval of the Company’s shareholders in accordance with applicable law or regulation to either reduce the exercise price of any outstanding Option or Stock Appreciation Right, or cancel any outstanding Option or Stock Appreciation Right in exchange for cash, another Award, or another Option or Stock Appreciation Right with an exercise price that is less than the exercise price of the original Option or Stock Appreciation Right.

The Committee shall have the power and authority to determine which individuals, including individuals outside the United States, shall be eligible to receive Awards under the Plan. The Committee may adopt, amend or rescind rules, procedures or sub-plans relating to the operation and administration of the Plan to accommodate the specific requirements of local laws, procedures, and practices. Without limiting the generality of the foregoing, the Committee is specifically authorized to adopt rules, procedures and sub-plans with provisions that limit or modify rights on death, disability, retirement, separation from service or termination of employment, available methods of exercise or settlement of an Award, payment of income, social insurance contributions and payroll taxes, withholding procedures and handling of any stock certificates or other indicia of ownership which vary with local requirements. The Committee may also adopt rules, procedures or sub-plans applicable to Participants employed by particular Employers or at particular locations.

5. Options.

The Committee, in its discretion, may grant Options which are Incentive Stock Options or Non-Qualified Stock Options, as evidenced by the Award Agreement, and shall be subject to the foregoing and the following terms and conditions and to such other terms and conditions, not inconsistent therewith, as the Committee shall determine:

A. Type of Option. Incentive Stock Options may be granted to any individual classified by the Committee as an employee of the Company, a Parent or a Subsidiary. A Non-Qualified Stock Option may be granted to any individual selected by the Committee, provided that in no event shall a Non-Qualified Stock Option be granted in exchange for services performed by an individual unless the Company is an “eligible issuer of service recipient stock” within the meaning of Code Section 409A with respect to such individual. No individual may be granted Options to purchase more than 1,000,000 shares of Stock during any single fiscal year of the Company.

B. Option Prices. The purchase price of the Stock under each Option shall not be less than 100% of the Fair Market Value of the Stock at the time of the granting of the Option, as determined under Section 16; provided that, in the case of a Participant who owns more than 10% of the total combined voting power of all classes of stock of the Company, a Parent or a Subsidiary (as determined in accordance with Code Section 422), the purchase price of the Stock under each Incentive Stock Option shall not be less than 110% of the Fair Market Value of the Stock on the date such Option is granted.

C. Exercise – Elections and Restrictions. The purchase price for an Option is to be paid in full upon the exercise of the Option, either (i) in cash, (ii) in the discretion of the Committee, by the tender to the Company (either actual or by attestation) of shares of Stock already owned by the Participant and registered in his or her name, having a Fair Market Value equal to the cash exercise price of the Option being exercised, (iii) through a net or cashless (including broker-assisted cashless exercise, to the extent permissible) form of exercise as permitted by the Committee, or (iv) in the discretion of the Committee, by any combination of the payment methods specified in clauses (i), (ii), or (iii) hereof; provided that, no shares of Stock may be tendered in exercise of an Incentive Stock Option if such shares were acquired by the Participant through the exercise of an Incentive Stock Option unless (a) such shares have been held by the Participant for at least one year and (b) at least two years have elapsed since such prior Incentive Stock Option was granted.

D. Option Terms. The term of each Option shall not be more than ten (10) years from the date of granting thereof, as determined under Section 16, or such shorter period as is prescribed in the Award Agreement; provided that, in the case of a Participant who owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company, a Parent or a Subsidiary, the term of any Incentive Stock Option shall not be more than five (5) years from the date of granting thereof or such shorter period as prescribed in the Award Agreement. Within such limit, Options will be exercisable at such time or times, and subject to such restrictions and conditions, as the Committee shall, in each instance, approve, which need not be uniform for all Participants. The holder of an Option shall have none of the rights of a shareholder with respect to the shares subject to Option until such shares shall be issued to him or her upon the exercise of his or her Option. In no event shall Option holders be entitled to dividends or dividend equivalents with respect to such Options.

E. Successive Option Grants. As determined by the Committee, successive option grants may be made to any Participant under the Plan.

F. Additional Incentive Stock Option Requirements. The maximum aggregate Fair Market Value (determined at the time an Option is granted) of the Stock with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year (under all plans of the Company, a Parent and a Subsidiary) shall not exceed $100,000. A Participant who disposes of Stock acquired upon the exercise of an Incentive Stock Option either (i) within two years after the date of grant of such Incentive Stock Option or (ii) within one year after the transfer of such shares to the Participant, shall notify the Company of such disposition and of the amount realized upon such disposition.

6. Stock Appreciation Rights.

A. Grant Terms. The Committee may grant a Stock Appreciation Right independent of an Option or in connection with an Option or a portion thereof. A Stock Appreciation Right granted in connection with an Option or a portion thereof shall cover the same shares of Stock covered by the Option, or a lesser number as the Committee may determine. The maximum number of shares of Stock subject to Awards for Stock Appreciation Rights for grants intended to qualify as Performance-Based Awards during a calendar year shall be 1,000,000. The term of each Stock Appreciation Right shall not be more than ten (10) years from the date of granting thereof, as determined under Section 16, or such shorter period as is prescribed in the Award Agreement.

B. Exercise Terms. The exercise price per share of Stock of a Stock Appreciation Right shall not be less than 100% of the Fair Market Value of the Stock at the time of granting, as determined under Section 16, the Stock Appreciation Right. A Stock Appreciation Right granted independent of an Option shall entitle the Participant upon exercise to a payment from the Company in an amount equal to the excess of the Fair Market Value on the exercise date of a share of Stock over the exercise price per share, times the number of Stock Appreciation Rights exercised. A Stock Appreciation Right granted in connection with an Option shall entitle the Participant to surrender an unexercised Option (or portion thereof) and to receive in exchange an amount equal to the excess of the Fair Market Value on the exercise date of a share of Stock over the exercise price per share for the Option, times the number of shares covered by the Option (or portion thereof) which is surrendered. Payment may be made, in the discretion of the Committee, in (i) Stock, (ii) cash or (iii) any combination of Stock and cash. Cash shall be paid for fractional shares of Stock upon the exercise of a Stock Appreciation Right.

C. Limitations. The Committee may include in the Award Agreement such conditions upon the exercisability or transferability of Stock Appreciation Rights as it determines in its sole discretion. In no event shall Stock Appreciation Right holders be entitled to dividends or dividend equivalents with respect to such Stock Appreciation Rights.

7. Other Stock-Based Awards and Cash-Based Awards.

The Committee may, in its sole discretion, grant Awards of Stock, restricted Stock, restricted Stock units and other Awards that are valued in whole or in part by reference to the Fair Market Value of Stock. These Awards shall collectively be referred to herein as Other Stock-Based Awards. The Committee may also, in its sole discretion, grant Cash-Based Awards, which shall have a value as may be determined by the Committee. Other Stock-Based Awards shall be in such form, and dependent on such conditions, if any, as the Committee shall determine, including, but not limited to, the right to receive fully-vested shares or the right to receive one or more shares of Stock (or the cash-equivalent thereof) upon the completion of a specified period of service, the occurrence of an event or the attainment of performance objectives. Other Stock-Based Awards and Cash-Based Awards may be granted with or in addition to other Awards. Subject to the other terms of the Plan, Other Stock-Based Awards and Cash-Based Awards may be granted to such Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee and set forth in an Award Agreement; provided that, the maximum Cash-Based Award that may be granted to a Participant in a calendar year is $1,000,000 to the extent it is also a Performance-Based Award. Notwithstanding the foregoing, no dividends or dividend equivalents shall be paid with respect to unvested Other Stock-Based Awards, including Other Stock-Based Awards that are intended to be Performance-Based Awards.

8. Performance-Based Awards.

The Committee may, in its sole and absolute discretion, determine that certain Awards should be subject to such requirements so that they are deductible by the Employer under Code Section 162(m). If the Committee so determines, such Awards shall be considered Performance-Based Awards subject to the terms of this Section 8, as provided in the Award Agreement. A Performance-Based Award shall be granted by the Committee in a manner to satisfy the requirements of Code Section 162(m) and the regulations thereunder. The performance measures to be used for purposes of a Performance-Based Award shall be determined by the Committee, in its sole and absolute discretion, from among the following: the Company’s earnings per share growth; earnings; earnings per share; cash flow; working capital; expense management; customer satisfaction; revenues; financial return ratios; market performance; shareholder return and/or value; operating income (loss) (including earnings (loss) before income taxes, depreciation and amortization); net income (loss); profit returns; margins; stock price; working capital; business trends; production cost; product cost; return on assets; project milestones; and plant and equipment performance. The performance measures may relate to the Company, a Parent, a Subsidiary, an Employer or one or more units of such an entity.

The Committee shall determine whether, with respect to a performance period, the applicable performance goals have been met with respect to an Award and, if they have, to so certify and ascertain the amount of the applicable Performance-Based Award. Each performance measure that constitutes a criteria measured by reference to the Company’s financial statements shall be determined in accordance with generally accepted accounting principles as consistently applied by the Company and, if so determined by the Committee prior to the date the performance measures are established in writing, adjusted, to the extent permitted under Code Section 162(m), to omit the effects of extraordinary items, gain or loss on the disposal of a business segment, unusual or infrequently occurring events and transactions and cumulative effects of changes in accounting principles. The Committee shall have the discretion to adjust the amount payable on a Company-

wide or divisional basis or to reflect individual performance and/or unanticipated factors; provided, however, that Awards which are designed to qualify as Performance-Based Awards may not be adjusted upward (the Committee shall retain the discretion to adjust such Awards downward).

9. Vesting Limitations.

Except as otherwise provided in this Plan, each Stock Option and Stock Appreciation Right shall have a minimum vesting period of three years from the date of grant of such award, provided that such vesting may occur incrementally over such three-year period. Except as otherwise provided in this Plan, the vesting schedule of any such Award may not accelerate except in the case of death, disability, retirement, a Change of Control, involuntary termination of employment without cause or voluntary termination for good reason. Except as otherwise provided in this Plan, whether an Award will be subject to accelerated vesting upon the occurrence of one or more of these events shall be specified in Award Agreement relating to such Award or another agreement with the Participant, such as an employment agreement.

10. Withholding. Upon exercise of an Option, the Company shall withhold a sufficient number of shares to satisfy the Company’s minimum required statutory withholding obligations for any taxes incurred as a result of such exercise (based on the minimum statutory withholding rates for federal and state tax purposes, including payroll taxes); provided that, in lieu of all or part of such withholding, the Participant may pay an equivalent amount of cash to the Company. Prior to the payment, settlement, or vesting of any Award other than an Option, the Participant shall pay to the Company, or make arrangements acceptable to the Company for the payment of, amounts sufficient for the Company to satisfy its required statutory withholding obligations. The Company shall have the right to satisfy its required statutory withholding obligations by withholding an amount of cash otherwise due to a Participant (or shares of Stock for Awards settled in shares of Stock) upon the settlement of any Award.

11. Nontransferability of Awards.

Unless otherwise determined by the Committee and expressly set forth in an Award Agreement, an Award granted under the Plan shall, by its terms, be non-transferable otherwise than by will or the laws of descent and distribution and an Award may be exercised, if applicable, during the lifetime of the Participant thereof, only by the Participant or his or her guardian or legal representative. Notwithstanding the above, the Committee may not provide in an Award Agreement that an Incentive Stock Option is transferable.

12. Investment Purpose.

Each Award under the Plan shall be awarded only on the condition that all purchases of Stock thereunder shall be for investment purposes, and not with a view to resale or distribution, except that the Committee may make such provision with respect to Awards granted under this Plan as it deems necessary or advisable for the release of such condition upon the registration with the Securities and Exchange Commission of Stock subject to the Award, or upon the happening of any other contingency warranting the release of such condition.

13. Adjustments Upon Changes in Capitalization or Corporation Acquisitions.

In the event of any change in the outstanding Stock of the Company by reason of a stock split, stock dividend, combination or reclassification of shares, recapitalization, consolidation, split-up, merger, or similar event, the Committee shall adjust appropriately: (a) the number of shares or kind of Stock (i) available for issuance under the Plan, (ii) for which Awards may be granted to an individual Participant, and (iii) covered by outstanding Awards denominated in stock or units of stock; (b) the exercise and grant prices related to outstanding Awards; and (c) the appropriate Fair Market Value and other price determinations for such Awards. In the event of any other change affecting the Stock or any distribution (other than normal cash dividends) to holders of Stock, such adjustments in the number and kind of shares and the exercise, grant and conversion prices of the affected Awards as may be deemed equitable by the Committee, including adjustments to avoid fractional shares, shall be made to give proper effect to such event. In the event of a corporate merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation, the Committee shall be authorized to cause to issue or assume stock options, whether or not in a transaction to which section 424(a) of the Code applies, by means of substitution of new stock options for previously issued stock options or an assumption of previously issued stock options. In such event, the aggregate number of shares of Stock available for issuance under Awards under Section 3, including the individual Participant maximums, will be increased to reflect such substitution or assumption.

In the event of a Change of Control, notwithstanding any other provisions of the Plan or an Award Agreement to the contrary, the Committee may, in its sole discretion, provide for:

(1) Termination of an Award upon the consummation of the Change of Control in exchange for the payment of a cash amount (but only in a manner which does not result in a violation of Code Section 409A and only to the extent the terminated Award has, in the discretion of the Committee, a positive value as of the termination date); and/or

(2) Issuance of substitute Awards to substantially preserve the terms of any Awards previously granted under the Plan (but only in a manner which does not result in a violation of Code Section 409A) which are outstanding upon the consummation of the Change of Control.

Prior to the consummation of a Change of Control, the Committee may also provide for accelerated vesting of any outstanding Awards that are otherwise unexercisable or unvested as of a date selected by the Committee.

14. Amendment and Termination.

The Board or the Committee may at any time terminate the Plan, or make such modifications to the Plan as either shall deem advisable; provided, however, that the Board or the Committee may not, without further approval by the shareholders of the Company, increase the maximum number of shares as to which Awards may be granted under the Plan (except under the anti-dilution provisions of Section 13), or change the class of employees to whom Incentive Stock Options may be granted. No termination or amendment of the Plan may, without the consent of the Participant to whom any Award shall theretofore have been granted, adversely affect the rights of such Participant under such Award.

15. Effectiveness of the Plan.

The Plan shall become effective upon adoption by the Board or the Committee subject, however, to its further approval by the shareholders of the Company given within twelve (12) months of the date the Plan is adopted by the Board or the Committee at a regular meeting of the shareholders or at a special meeting duly called and held for such purpose. Grants of Awards may be made prior to such shareholder approval but all Award grants made prior to shareholder approval shall be subject to the obtaining of such approval and if such approval is not obtained, such Awards shall not be effective for any purpose.

16. Time of Granting of an Award.

An Award grant under the Plan shall be deemed to be made on the date on which the Committee, by formal action of its members duly recorded in the records thereof, makes an Award to a Participant (but in no event prior to the adoption of the Plan by the Board or the Committee).

17. Term of Plan.

This Plan shall terminate ten (10) years after the date on which it is approved and adopted by the Board or the Committee and no Award shall be granted hereunder after the expiration of such ten-year period. Awards outstanding at the termination of the Plan shall continue in accordance with their terms and shall not be affected by such termination.

18. No Right To Continued Employment.

Nothing in the Plan or in any Award granted pursuant to the Plan shall confer on any individual any right to continue in the employ of the Employer or interfere in any way with the right of the Employer to terminate his or her employment at any time.

19. Choice of Law.

The Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to conflicts of law. Unless otherwise provided in an Award Agreement, recipients of an Award under the Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of Missouri, County of St. Louis, to resolve any and all issues that may arise out of or relate to the Plan or any Award Agreement.

20. Severability. If any provision of the Plan is, becomes, or is deemed invalid, illegal, or unenforceable in any jurisdiction, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended or limited in scope to conform to applicable laws or, in the discretion of the Committee, it shall be stricken and the remainder of the Plan shall remain in full force and effect.

* * *

The foregoing amended and restated Plan was approved and adopted by the Committee on February 22, 2017, and approved by the Stockholders on May 23, 2017.

/s/Karen W. Duros

Secretary

EX-31.1 3 d439571dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

I, David L. Fischel, certify that:

I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-31.2 4 d439571dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

I, Martin C. Stammer, certify that:

I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-32.1 5 d439571dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David L. Fischel, Acting Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-32.2 6 d439571dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin C. Stammer, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

EX-101.INS 7 stxs-20170630.xml XBRL INSTANCE DOCUMENT 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel1Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel1Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel1Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel2Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel1Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel1Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel1Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeTwoMember 2017-01-01 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeThreeMember 2017-01-01 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeFourMember 2017-01-01 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember stxs:RangeOneMember 2016-01-01 2016-12-31 0001289340 us-gaap:EmployeeStockOptionMember 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember 2016-12-31 0001289340 2017-05-22 2017-05-23 0001289340 2016-05-23 2016-05-24 0001289340 2014-06-09 2014-06-10 0001289340 2013-06-04 2013-06-05 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2017-06-30 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001289340 us-gaap:RevolvingCreditFacilityMember us-gaap:MinimumMember 2016-05-10 0001289340 us-gaap:LeaseholdImprovementsMember 2017-06-30 0001289340 us-gaap:EquipmentMember 2017-06-30 0001289340 us-gaap:AssetsHeldUnderCapitalLeasesMember 2017-06-30 0001289340 us-gaap:LeaseholdImprovementsMember 2016-12-31 0001289340 us-gaap:EquipmentMember 2016-12-31 0001289340 us-gaap:AssetsHeldUnderCapitalLeasesMember 2016-12-31 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2013-01-30 2013-01-31 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2012-08-07 2012-08-08 0001289340 us-gaap:PrivatePlacementMember 2016-01-01 2016-12-31 0001289340 2016-01-01 2016-12-31 0001289340 us-gaap:RevolvingCreditFacilityMember 2017-01-01 2017-06-30 0001289340 us-gaap:RevolvingCreditFacilityMember 2017-06-30 0001289340 us-gaap:OfficeBuildingMember 2017-01-01 2017-06-30 0001289340 stxs:OfficeSubleaseTwoMember 2017-01-01 2017-06-30 0001289340 stxs:OfficeSubleaseMember 2017-01-01 2017-06-30 0001289340 stxs:CowenDebtMember 2016-01-01 2016-12-31 0001289340 stxs:WarrantsIssuedSeptember2016Member 2017-06-30 0001289340 stxs:WarrantsIssuedMay102012Member 2017-06-30 0001289340 stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember 2017-06-30 0001289340 stxs:WarrantsIssuedSeptember2016Member 2016-12-31 0001289340 stxs:WarrantsIssuedMay102012Member 2016-12-31 0001289340 stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedSeptember2016Member us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-06-30 0001289340 stxs:CowenDebtMember 2016-09-01 2016-09-30 0001289340 stxs:ProductShippedRevenueDeferredMember 2017-06-30 0001289340 stxs:DeferredServiceAndLicenseFeesMember 2017-06-30 0001289340 stxs:CustomerDepositsMember 2017-06-30 0001289340 stxs:ProductShippedRevenueDeferredMember 2016-12-31 0001289340 stxs:DeferredServiceAndLicenseFeesMember 2016-12-31 0001289340 stxs:CustomerDepositsMember 2016-12-31 0001289340 stxs:CowenDebtMember 2016-09-30 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2017-01-01 2017-06-30 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2011-11-30 0001289340 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001289340 us-gaap:PreferredStockMember 2016-01-01 2016-12-31 0001289340 2016-09-29 0001289340 us-gaap:WarrantMember 2017-06-30 0001289340 us-gaap:PreferredStockMember 2017-06-30 0001289340 2016-06-30 0001289340 2015-12-31 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001289340 us-gaap:OfficeBuildingMember 2017-06-30 0001289340 stxs:DemonstrationAndAssemblyMember 2017-06-30 0001289340 us-gaap:OfficeBuildingMember 2015-12-31 0001289340 us-gaap:WarrantMember 2017-01-01 2017-06-30 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001289340 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001289340 stxs:OfficeSubleaseTwoMember 2017-01-31 0001289340 stxs:OfficeSubleaseMember 2016-08-31 0001289340 us-gaap:OtherPropertyMember 2013-09-30 0001289340 2016-09-29 2016-09-29 0001289340 us-gaap:RevolvingCreditFacilityMember 2016-05-10 0001289340 stxs:WarrantsIssuedSeptember2016Member 2017-01-01 2017-06-30 0001289340 stxs:WarrantsIssuedMay102012Member 2017-01-01 2017-06-30 0001289340 stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember 2017-01-01 2017-06-30 0001289340 2017-04-01 2017-06-30 0001289340 2016-04-01 2016-06-30 0001289340 2016-01-01 2016-06-30 0001289340 us-gaap:PrivatePlacementMember 2014-05-01 2014-05-31 0001289340 stxs:CowenDebtMember us-gaap:LoansPayableMember 2011-11-01 2011-11-30 0001289340 2017-06-30 0001289340 2016-12-31 0001289340 us-gaap:OtherPropertyMember 2017-06-30 0001289340 stxs:OfficeSubleaseMember 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedMay102012Member us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedAugustTenthTwoThousandThirteenMember us-gaap:FairValueMeasurementsRecurringMember 2017-01-01 2017-06-30 0001289340 us-gaap:FairValueInputsLevel3Member stxs:WarrantsIssuedSeptember2016Member 2017-01-01 2017-06-30 0001289340 2017-07-31 0001289340 2017-01-01 2017-06-30 iso4217:USD xbrli:shares utr:sqft stxs:item xbrli:pure iso4217:USD xbrli:shares false --12-31 Q2 2017 2017-06-30 10-Q 0001289340 22753121 Smaller Reporting Company Stereotaxis, Inc. stxs 2021-09-01 2018-11-01 2018-05-01 38633 138528 561450 573378 5000000 18000000 P180D 1796888 699173 2317911 1281729 13511632 6938645 13397364 6638587 -3429563 -116070 -64262 -3249231 -24000000 -24500000 1.00 0.50 0.030 24000000 <div> <div style="margin-left:0pt;margin-right:0pt;"> Revenue and Costs of Revenue  The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”). ASC 605-25 permits management to estimate the selling price of undelivered components of a bundled sale for which it is unable to establish vendor-specific objective evidence (“VSOE”) or third-party evidence (“TPE”). This requires management to record revenue for certain elements of a transaction even though it might not have delivered other elements of the transaction, for which it was unable to meet the requirements for establishing VSOE or TPE. The Company believes that the guidance significantly improves the reporting of these types of transactions to more closely reflect the underlying economic circumstances. This guidance also prohibits the use of the residual method for allocating revenue to the various elements of a transaction and requires that the revenue be allocated proportionally based on the relative estimated selling prices. Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future. Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred. </div> </div> P1Y 1478996 395898 1140961 920517 3010997 935978 2047334 1828439 1

<div> <div style="margin-left:0pt;margin-right:0pt;"> 7. Accrued Liabilities Accrued liabilities consist of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> June 30, </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> December 31, </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> 2017 </td> <td valign="top" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:18.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Accrued salaries, bonus, and benefits </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $     2,197,612 </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $    2,452,183 </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Accrued rent </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">640,496  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">965,412  </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Accrued licenses and maintenance fees </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">573,378  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">561,450  </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Accrued warranties </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">181,308  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">222,845  </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Accrued taxes </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">267,164  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">219,017  </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Accrued professional services </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">112,500  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">180,450  </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Other </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">236,369  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">210,216  </td> </tr> <tr> <td valign="bottom" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total accrued liabilities </td> <td valign="bottom" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,208,827  </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">4,811,573  </td> </tr> <tr> <td valign="top" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Less: Long term accrued liabilities </td> <td valign="bottom" style="width:19.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(321,316) </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(320,409) </td> </tr> <tr> <td valign="bottom" style="width:57.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total current accrued liabilities </td> <td valign="bottom" style="width:19.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $     3,887,511 </td> <td valign="bottom" style="width:04.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $    4,491,164 </td> </tr> </table></div> Our primary company facilities are located in St. Louis, Missouri where we currently lease approximately 52,000 square feet of office and 12,000 square feet of demonstration and assembly space. In the third quarter of 2013, the Company modified the existing lease agreement to terminate approximately 13,000 square feet of unimproved space. The costs associated with the termination were $515,138 and were accrued as a rent liability as of September 30, 2013. As of June 30, 2017, the remaining accrued costs associated with the termination were $138,528. In the fourth quarter of 2015, the Company entered an agreement to sublease 3,152 square feet of the first floor office space through December 31, 2018.  In July 2016, the Company and the subtenant mutually agreed to an early termination of the sublease, effective July 31, 2016.  In August 2016 the Company entered into an agreement to sublease approximately 11,000 square feet of office space through December 31, 2018.  The costs associated with the sublease were $40,972 and were accrued as a rent liability as of August 31, 2016.  In January 2017, as part of the sublease agreement, the Company subleased an additional 16,000 square feet through December 31, 2018.  The costs associated with the January sublease were $28,208.  As of June 30, 2017, the remaining accrued costs associated with the termination were $38,633. </div> </div>

2623010

1737247

4665959

4876716

219017

267164

4491164

3887511

4811573

4208827

180450

112500

515138

40972

965412

28208

640496

10334556

9058558

449939406

450370408

379817

603588

108850

49588

99660

99661

645885

628775

38779119

13000

3152

11000

16000

12000

52000

20965803

16684028

19403749

15513706

<div> <div style="margin-left:0pt;margin-right:0pt;"> Basis of Presentation The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the six month period ended June  30, 2017 are not necessarily indicative of the results that may be expected for the year ended December 31, 2017 or for future operating periods. These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission (SEC) on March 16, 2017. </div> </div>

5593582

3858089

8501392

5035463

791

-1735493

-3465929

0.70

0.65

0.82

36923078

38463078

38779119

0.001

300000000

22063582

22612043

22064

22612

100

155439

3275884

1095071

3458872

2202246

<div> <div style="margin-left:0pt;margin-right:0pt;"> 9. Long-Term Debt and Credit Facilities  <a name="FIS_UNIDENTIFIED_TABLE_7"></a>    Revolving Line of Credit The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $10.0 million subject to the value of collateralized assets. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender. The facility was amended on March 27, 2015, extending the maturity date to March 31, 2018 and on May 10, 2016, the Company and the primary lender agreed to modify certain financial covenants.  The amended agreement requires the Company to maintain a liquidity ratio greater than 1.50:1.00, excluding certain short term advances from the calculation, and a minimum tangible net worth of not less than (no worse than) negative $24.0 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, and September 30, 2017; and not less than (no worse than) negative $24.5 million for the quarters ended December 31, 2017 and March 31, 2018. As of June 30, the Company is in compliance with its loan covenants. As of June  30, 2017, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit are made based on the borrowing capacity one week in arrears. As of June  30, 2017, the Company had a borrowing capacity of $3.9 million based on the Company’s collateralized assets.  The Company’s total liquidity as of June  30, 2017,  was $8.9 million which included cash and cash equivalents of $5.0 million.  Healthcare Royalty Partners Debt In November 2011, the Company entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed $15 million from Healthcare Royalty Partners. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the nine months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012.  The loan was to be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis' Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners was entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan was repaid.  The loan was a full recourse loan, scheduled to mature on December 31, 2018, and included interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement were insufficient to pay all amounts of interest due on the loan, then such deficiency would have increased the outstanding principal amount on the loan. The loan was also secured by certain assets and intellectual property of the Company. The agreement also contained customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender. In September 2016, the Company extinguished the remainder of the debt of $18.1 million, net of deferred financing costs of approximately $0.3 million, as well as accrued interest of $0.5 million for $13.0 million based upon an agreement entered into with Healthcare Royalty Partners.  Following the repayment of the loan obligation, the royalties under the Biosense Agreement are now paid to the Company. As a result of the debt extinguishment, the Company recognized a net gain of $5.6 million in 2016. </div> </div>

0.16

2018-12-31

24658

75068

300000

9273665

2910000

5813956

549709

8478743

1455000

6358017

665726

8751336

8101667

<div> <div style="margin-left:0pt;margin-right:0pt;"> 8. Deferred Revenue Deferred revenue consists of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> June 30, </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> December 31, </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> 2017 </td> <td valign="top" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:19.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:19.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Product shipped, revenue deferred </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        665,726 </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        549,709 </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Customer deposits </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,455,000  </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,910,000  </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Deferred service and license fees </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,358,017  </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">5,813,956  </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total deferred revenue </td> <td valign="bottom" style="width:19.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,478,743  </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">9,273,665  </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Less: Long-term deferred revenue </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(377,076) </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(522,329) </td> </tr> <tr> <td valign="top" style="width:52.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total current deferred revenue </td> <td valign="bottom" style="width:19.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $     8,101,667 </td> <td valign="bottom" style="width:07.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:19.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $     8,751,336 </td> </tr> </table></div> </div> </div>

522329

377076

293992

254987

185802

277402

166664

3429563

-0.21

-0.11

0.00

-0.02

-0.21

-0.11

0.00

-0.02

<div> <div style="margin-left:0pt;margin-right:0pt;"> Net Earnings (Loss) per Common Share (“EPS”) Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. We apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses.  We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive. The following table sets forth the computation of basic and diluted EPS: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Six months ended June 30, </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Net income (loss) </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(177,299) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">999,669  </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Cumulative dividend on convertible preferred stock </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(369,661) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(732,849) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Net income attributable to convertible preferred stock </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(167,539) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Earnings (net loss) attributable to common stockholders </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(546,960) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">99,281  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;"> Shares used for basic EPS-weighted average shares </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,581,330  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,450,392  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Effect of dilutive securities: </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Restricted Stock Units </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,087  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Stock Options, Appreciation Rights and Warrants </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Weighted average shares used in computing earnings (net loss) per share </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,581,330  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,458,479  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Basic EPS </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.02) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted EPS </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.02) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> </table></div> The following potential common shares were excluded from diluted EPS for the six months ended June 30, 2017 as they were antidilutive:  645,885 stock options and stock appreciation rights, 628,775 restricted stock units, and 38,779,119 warrants. In addition, the Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights or warrants in the calculation of diluted loss per common share for the three months ended June 30, 2017 or the three and six months ended June 30, 2016 because all such securities are anti-dilutive for the period. The Company had no unearned restricted shares during either period. As of June  30, 2017, the Company had 645,885 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $7.01 per share,  38,779,119 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.82 per share, 38,463,078 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends at an exercise price of $0.65 per share, and 636,862 shares of unvested restricted share units. <a name="eolPage9"></a> </div> </div>

2452183

2197612

900000

P4Y

18100000

0.9283

0.7992

1.1782

0.0124

0.0189

<div> <div style="margin-left:0pt;margin-right:0pt;"> 11. Fair Value Measurements  The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents and warrants. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below: Level 1: Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2: Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market. Level 3: Values are generated from model-based techniques that use significant assumptions not observable in the market. The following table sets forth the Company’s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy.  As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:07.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:31.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> </table></div> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td colspan="8" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Fair Value Measurement Using </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Instruments (Level 1) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at June 30, 2017: </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">791  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">791  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Liabilities at June 30, 2017: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,819  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,819  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,625  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,625  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued September 2016 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,320,000  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,320,000  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,357,444  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,357,444  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at December 31, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Liabilities at December 31, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">66,081  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">66,081  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">151,695  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">151,695  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued September 2016 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,569,231  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,569,231  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,787,007  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,787,007  </td> </tr> </table></div> Level 1 The Company’s financial assets consist of cash equivalents invested in money market funds in the amount of $791 and $0 at June 30, 2017 and December 31, 2016, respectively. These assets are classified as Level 1 as described above and total interest income recorded for these investments was insignificant during both the six month periods ended June 30, 2017, and June 30, 2016. There were no transfers in or out of Level 1 during the period ended June 30, 2017. Level 2 The Company does not have any financial assets or liabilities classified as Level 2. Level 3  In conjunction with the Company’s May 2012, August 2013 and September 2016 financing transactions, the Company issued warrants to purchase shares of the Company’s common stock. Due to the provisions included in the warrant agreements, the warrants did not meet the exemptions for equity classification and as such, the Company accounts for these warrants as derivative instruments. The calculated fair value of the warrants is classified as a liability and is periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations. The remaining warrants from the May 2012 transaction (PIPE Warrants) expire in May 2018 and were revalued as of June  30, 2017 using the following assumptions: 1) volatility of 79.92%; 2) risk-free interest rate of 1.24%; and 3) a closing stock price of $0.58.  The remaining warrants from the August 2013 transaction (Exchange Warrants) expire in November 2018 and were revalued as of June 30, 2017 using the following assumptions: 1) volatility of 92.83%; 2) risk-free interest rate of 1.24%; and 3) a closing stock price of $0.58.   The remaining warrants from the September 2016 transaction expire in September 2021 and were valued as of June 30, 2017 using the following assumptions: 1) volatility of 117.82%; 2) risk-free interest rate of 1.89%; and 3) a closing stock price of $0.58.  The significant unobservable input used in the fair value measurement of the Company’s warrants is volatility.  Significant increases (decreases) in the volatility in isolation would result in significantly higher (lower) liability fair value measurements. The following table sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the six month period ended June  30, 2017: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Warrants issued May 2012 </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Warrants issued August 2013 </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Warrants issued September 2016 </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:49.50pt;padding:0pt;"> Total Liabilities </td> </tr> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Balance at beginning of period </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $                66,081 </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $          151,695 </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        19,569,231 </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $       19,787,007 </td> </tr> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">     Issues </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">     Settlements </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> - </td> </tr> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">     Revaluation </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(64,262) </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(116,070) </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,249,231) </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(3,429,563) </td> </tr> <tr> <td valign="bottom" style="width:30.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Balance at end of period </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $                  1,819 </td> <td valign="bottom" style="width:02.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $            35,625 </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $        16,320,000 </td> <td valign="bottom" style="width:03.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $       16,357,444 </td> </tr> </table></div> The Company currently does not have derivative instruments to manage its exposure to currency fluctuations or other business risks. The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. All derivative financial instruments are recognized in the balance sheet at fair value.   </div> </div>

19787007

151695

66081

19569231

16357444

35625

1819

16320000

<div> <div style="margin-left:0pt;margin-right:0pt;"> Financial Instruments Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value. The Company measures certain financial assets and liabilities, including warrants, at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). See Note 11 for additional details. </div> </div>

2884161

3221069

436569

336908

-20772

5600000

5372838

2786046

4785546

1945676

13246745

6779552

11985826

6264780

587562

-885763

-1318967

210757

-627335

-603653

-1398213

-794922

806755

-396988

13081

1806

-5307

907

-147942

-288295

8087

1648066

829046

92267

42776

500000

<div> <div style="margin-left:0pt;margin-right:0pt;">   3. Inventories  Inventories consist of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:19.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:19.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> June 30, 2017 </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> December 31, 2016 </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:19.68%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:25.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Raw materials </td> <td valign="bottom" style="width:19.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $    2,435,855 </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $         2,397,430 </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Work in process </td> <td valign="bottom" style="width:19.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">403,863  </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">341,125  </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Finished goods </td> <td valign="bottom" style="width:19.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,502,343  </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,915,162  </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Reserve for obsolescence </td> <td valign="bottom" style="width:19.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(357,946) </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(272,614) </td> </tr> <tr> <td valign="top" style="width:48.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total inventory </td> <td valign="bottom" style="width:19.68%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $    4,984,115 </td> <td valign="bottom" style="width:06.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:25.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $         5,381,103 </td> </tr> </table></div> </div> </div>

2915162

2502343

5381103

4984115

2397430

2435855

272614

357946

341125

403863

362

140

2018-12-31

36495255

30782261

20965803

16684028

35652517

30083869

19787007

16357444

3900000

2018-03-31

10000000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 1. Description of Business Stereotaxis designs, manufactures and markets the Epoch Solution, which is an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency and efficacy for catheter-based, or interventional, procedures. The Epoch Solution is comprised of the Niobe ES Remote Magnetic Navigation System (“Niobe ES system”), Odyssey Information Management Solution (“Odyssey Solution”), and the Vdrive Robotic Navigation System (“Vdrive system”), and related devices. The Niobe system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. As of June 30, 2017, the Company had an installed base of 128 Niobe ES systems. In addition to the Niobe system and its components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation and training. Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems. We promote the full Epoch Solution in a typical hospital implementation, subject to regulatory approvals or clearances. The full Epoch Solution implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and software licenses. In hospitals where the full Epoch Solution has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion. The core components of Stereotaxis systems, such as the Niobe system, Odyssey Solution, Cardiodrive and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo systems with the V-CAS,  V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union. We have alliances with each of Biosense Webster, Inc., Philips Medical Systems, and Siemens AG Medical Solutions, through which we integrate our Niobe system with their respective digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of such alliances, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue indefinitely and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot assure as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all. The Company believes the cash on hand at June 30, 2017 and expected borrowing capacity available will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. This evaluation assumes the Company is able to renew and has the ability to borrow under its asset based revolving credit facility which matures on March 31, 2018. The Company expects to be able to renew this facility at similar terms, as it has successfully done so in the past. There is no assurance that the revolving credit facility will be renewed in a timely manner, in amounts that are sufficient to meet the Company’s obligations as they become due, or on terms acceptable to the Company, or at all. The Company has sustained operating losses throughout its corporate history and expects that its 2017 expenses will exceed its 2017 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. Accordingly, management has analyzed its planned operations to evaluate the Company’s ability to continue as a going concern.  The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of Niobe systems as well as by new placements of capital systems. The Company’s plans for improving its liquidity conditions, which are probable of effectively being implemented, primarily include its ability to control the timing and spending of its operating expenses and raising additional funds through capital transactions. Specifically, cash outflows for operating expenses could be reduced or delayed by transitioning certain cash payments to stock payments, by reducing project expenses, or by reducing headcount. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.     </div> </div>

8900000

2873521

-81128

-4297

-4609014

-3380504

-4607417

-2333116

999669

-177299

-4607417

-2333116

99281

-546960

<div> <div style="margin-left:0pt;margin-right:0pt;"> Recently Issued Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” or “Update”) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” This amendment is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. This update is effective for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company) and interim periods within those fiscal years, with earlier application permitted. The Company adopted this guidance in the first quarter of 2017.  The adoption of ASU 2016-09 did not materially impact the Company’s consolidated financial position, results of operations, equity or cash flows. In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” regarding the subsequent measurement of inventory as part of its Simplification Initiative. This standard is effective for public companies for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company), including interim periods within those fiscal years. This Update should be applied prospectively, and early application is permitted as of the beginning of an interim or annual reporting period. The Company adopted this accounting standard update in the first quarter of 2017. The adoption of ASU 2015-11 did not materially impact the company’s results of operations, financial conditions, cash flows, or financial statement presentation. In February 2016, the FASB issued ASU 2016-02, “Leases (ASC 842),” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840 Leases. The standard is effective for interim and annual periods beginning after December 31, 2018 (January 1, 2019 for the Company), with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update. In August 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-15, to communicate amendments to FASB Account Standards Codification Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The ASU requires management to evaluate relevant conditions, events and certain management plans that are known or reasonably knowable as of the evaluation date when determining whether substantial doubt about an entity’s ability to continue as a going concern exists. Management will be required to make this evaluation for both annual and interim reporting periods. Management will have to make certain disclosures if it concludes that substantial doubt exists or when it plans to alleviate substantial doubt about the entity’s ability to continue as a going concern. The standard is effective for annual periods ending after December 15, 2016 and for interim reporting periods starting in the first quarter of 2017 (December 31, 2016 for the Company). Early adoption is permitted. The Company adopted this accounting standard update effective December 31, 2016 and provided the relevant disclosures in Note 1.  In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB’s and the International Accounting Standards Board’s current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. The Company will adopt ASU 2014-09 during the first quarter of 2018 and anticipates using the modified retrospective method that will result in a cumulative effect adjustment as of the date of adoption. Upon initial evaluation, management does not anticipate a significant change to its existing units of accounting which include systems, disposables and other accessories, royalty and other recurring revenue. The Company continues to evaluate other areas of the standard and its effect on the Company’s financial statements. </div> </div>

16373122

8419132

14323462

6699559

-3126377

-1639580

-2337636

-434779

210216

236369

320409

321316

39241

41047

166664

135370

3429563

300255

100000

4297

6100000

0.06

732849

369661

1000

0.001

0.65

10000000

24000

23900

894536

658459

855295

617412

39241

41047

575886

328404

23000000

15000000

2500000

3000000

-2770

18872

316835

222845

181308

197733

76765

103743

35228

<div> <div style="margin-left:0pt;margin-right:0pt;"> 12. Product Warranty Provisions  The Company’s standard policy is to warrant all Niobe,  Odyssey, and Vdrive systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate. Accrued warranty, which is included in other accrued liabilities, consists of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> June 30, 2017 </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> December 31, 2016 </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Warranty accrual, beginning of the fiscal period </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">222,845  </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">316,835  </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Accrual adjustment for product warranty </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,228  </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">103,743  </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Payments made </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(76,765) </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(197,733) </td> </tr> <tr> <td valign="bottom" style="width:46.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Warranty accrual, end of the fiscal period </td> <td valign="top" style="width:09.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">181,308  </td> <td valign="bottom" style="width:05.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:17.32%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">222,845  </td> </tr> </table></div> </div> </div>

11420800

303412

8397528

2719860

9850925

7258587

2592338

1086244

792367

1.50

5960475

23709

13000000

2894465

1421380

2439697

1281264

-471245398

-470245729

16522629

7874623

15444698

8467026

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Six months ended June 30, </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Net income (loss) </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(177,299) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">999,669  </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Cumulative dividend on convertible preferred stock </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(369,661) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(732,849) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Net income attributable to convertible preferred stock </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(167,539) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Earnings (net loss) attributable to common stockholders </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(546,960) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">99,281  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;"> Shares used for basic EPS-weighted average shares </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,581,330  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,450,392  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Effect of dilutive securities: </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Restricted Stock Units </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,087  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Stock Options, Appreciation Rights and Warrants </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Weighted average shares used in computing earnings (net loss) per share </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,581,330  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,458,479  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Basic EPS </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.02) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted EPS </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.02) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> </table></div> </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td colspan="8" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Fair Value Measurement Using </td> </tr> <tr> <td valign="bottom" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Instruments (Level 1) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:04.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:74.25pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at June 30, 2017: </td> <td valign="bottom" style="width:02.14%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">791  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">791  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Liabilities at June 30, 2017: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,819  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,819  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,625  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,625  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued September 2016 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,320,000  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,320,000  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,357,444  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,357,444  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Assets at December 31, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Cash equivalents </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total assets at fair value </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Liabilities at December 31, 2016: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued May 2012 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">66,081  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">66,081  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued August 2013 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">151,695  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">151,695  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">          Warrants issued September 2016 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,569,231  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,569,231  </td> </tr> <tr> <td valign="top" style="width:38.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Total liabilities at fair value: </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.74%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,787,007  </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> —   </td> <td valign="bottom" style="width:04.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.56%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,787,007  </td> </tr> </table></div> </div> </div>

8105819

4211706

7098219

3472619

566975

412678

P4Y

44500

1.51

30000

0.68

1167099

636862

1.48

1.21

515737

1.76

1000000

1500000

4000000

5544098

36002

10000

671887

645885

8.77

7.01

38.16

0.62

1.45

2.15

0.62

116.40

54.90

0.62

<div> <div style="margin-left:0pt;margin-right:0pt;"> 10. Convertible Preferred Stock and Stockholders’ Equity The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement.  No dividends have been declared or paid as of June 30, 2017. Convertible Preferred Stock and Warrants On September 26, 2016, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors whereby it agreed to sell, for an aggregate purchase price of $24.0 million, (i) an aggregate of 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock.  The transaction closed on September 29, 2016. The Company received net proceeds from the sale of the convertible preferred stock and warrants of $23.0 million, after offering expenses. The Company used $13.0 million of the funds to satisfy in full all amounts outstanding under the Loan Agreement with Healthcare Royalty Partners, as noted above, and anticipates using the remaining proceeds for general corporate purposes. The designations, preferences, powers and rights of the convertible preferred shares are set forth in a Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (“Certificate of Designations”) filed with the Delaware Secretary of State. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Instead the value of the accrued dividends is added to the liquidation preference of the convertible preferred shares and will increase the number of shares of common stock issuable upon conversion. Each convertible preferred share is convertible at the option of the holder from and after the date of issuance with no expiration date, at an initial conversion price of $0.65 per share, subject to adjustment in the event of stock splits, dividends, mergers, sales of all or substantially all of our assets or similar transactions, subject to specified beneficial ownership issuance limitations. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a change of control as defined in the Certificate of Designations. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution and winding up of the Company. No such distributions or payments upon the liquidation, dissolution and winding up of the Company may be made to the holders of common stock unless and until the holders of convertible preferred shares have received the stated value of $1,000 per share plus any accrued and unpaid dividends. Until all convertible preferred shares have been converted or redeemed, no dividends may be paid on the common stock without the express written consent of the holders of a majority of the outstanding convertible preferred shares. In the event that dividends or other distributions of assets are made or paid by the Company to the holders of the common stock, the holders of convertible preferred shares are entitled to participate in such dividend or distribution on an as-converted basis. On the date of the issuance, the fair value of the convertible preferred stock was greater than the allocated proceeds received for the Series A Convertible Preferred Stock. As such, the Company accounted for the beneficial conversion feature under ASC 470-20, Debt with Conversion feature under ASC 470-20, Debt with Conversion and Other Options. The Company recorded a deemed dividend charge of $6.1 million for the accretion of a discount on the Series A Convertible Preferred Stock. The deemed dividend was a non-cash transaction and was reflected below net loss to arrive at net loss available to common stockholders in 2016. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.  The warrants issued in conjunction with the convertible preferred stock have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants may be exercised by any holder on a cashless basis if, at any time after the date that is 180 days after the closing, the registration statement required by the Registration Rights Agreement is not effective and available for resale of all of the shares of common stock issuable upon exercise of such holder’s warrants. Due to the fact that the warrants are puttable upon the occurrence of certain events outside of the Company’s control, the warrants qualify as liabilities under ASC 480-10. The calculated fair value of the warrants is classified as a liability and is periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations. See Note 11 for additional details. On December 2, 2016, 100 shares of convertible preferred stock plus accumulated dividends were converted into 155,439 common shares. Listing Transfer to OTCQX® Best Market     On August 2, 2016, the Company received a determination letter from the Nasdaq Hearings Panel (the “Panel”) notifying the Company that its common stock would be delisted from The Nasdaq Capital Market (“Nasdaq”) and that suspension of trading in the shares would be effective at the open of business on August 4, 2016. The delisting was completed by the filing of a Form 25 Notification of Delisting with the Securities Exchange Commission by Nasdaq on November 10, 2016. The Panel made the determination to delist the Company’s common stock because the Company did not demonstrate compliance with the minimum $35 million market value of listed securities requirement for a period of ten consecutive trading days by August 1, 2016, as required by a decision previously issued by the Panel on May 2, 2016. The Company’s shares of common stock commenced trading on the OTCQX® Best Market on August 4, 2016 under the Company’s current ticker symbol of “STXS.” Controlled Equity Offering The Company entered into a Controlled Equity OfferingSM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company paid Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement. There were no proceeds from the Controlled Equity Offering during the twelve months ended December 31, 2016. The Sales Agreement expired in November 2016 upon the expiration of our Registration Statement on Form S-3. Stock Award Plans The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation.  In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.  On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares.  At June 30, 2017, the Company had 5,544,098 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans. At June  30, 2017, the total compensation cost related to options, stock appreciation rights and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $0.9 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.  A summary of the option and stock appreciation rights activity for the six month period ended June 30, 2017 is as follows: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Number of Options/SARs </td> <td valign="bottom" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Range of Exercise Price </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Weighted Average Exercise Price per Share </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:18.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:24.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, December 31, 2016 </td> <td valign="top" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">671,887  </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $1.45 - $116.40 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$8.77  </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Granted </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">10,000  </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $0.62 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$0.62  </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Exercised </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  - </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  - </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">  - </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Forfeited </td> <td valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">(36,002) </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $2.15 - $116.40 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$38.16  </td> </tr> <tr> <td valign="top" style="width:34.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, June 30, 2017 </td> <td valign="top" style="width:18.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">645,885  </td> <td valign="top" style="width:03.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:17.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> $0.62 - $54.90 </td> <td valign="top" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:24.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$7.01  </td> </tr> </table></div>  <a name="FIS_UNIDENTIFIED_TABLE_9"></a> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:57.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> </table></div> A summary of the restricted stock unit activity for the six month period ended June  30, 2017 is as follows: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;"> Number of Restricted Stock Units </td> <td valign="bottom" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:56.25pt;padding:0pt;"> Weighted Average Grant Date Fair Value per Unit </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> </td> <td valign="top" style="width:20.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:23.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, December 31, 2016 </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,167,099  </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.48  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Granted </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">30,000  </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$0.68  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Vested </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(515,737) </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.76  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Forfeited </td> <td valign="top" style="width:20.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(44,500) </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:23.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.51  </td> </tr> <tr> <td valign="top" style="width:49.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;"> Outstanding, June 30, 2017 </td> <td valign="top" style="width:20.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">636,862  </td> <td valign="top" style="width:06.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;padding:0pt;">   </td> <td valign="top" style="width:23.58%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.00pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">$1.21  </td> </tr> </table></div> </div> </div>

0.58

<div> <div style="margin-left:0pt;margin-right:0pt;"> 2. Summary of Significant Accounting Policies  Basis of Presentation The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the six month period ended June  30, 2017 are not necessarily indicative of the results that may be expected for the year ended December 31, 2017 or for future operating periods. These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission (SEC) on March 16, 2017. Financial Instruments Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value. The Company measures certain financial assets and liabilities, including warrants, at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). See Note 11 for additional details. Revenue and Costs of Revenue  The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”). ASC 605-25 permits management to estimate the selling price of undelivered components of a bundled sale for which it is unable to establish vendor-specific objective evidence (“VSOE”) or third-party evidence (“TPE”). This requires management to record revenue for certain elements of a transaction even though it might not have delivered other elements of the transaction, for which it was unable to meet the requirements for establishing VSOE or TPE. The Company believes that the guidance significantly improves the reporting of these types of transactions to more closely reflect the underlying economic circumstances. This guidance also prohibits the use of the residual method for allocating revenue to the various elements of a transaction and requires that the revenue be allocated proportionally based on the relative estimated selling prices. Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future. Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred. Share-Based Compensation The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests. The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives. Net Earnings (Loss) per Common Share (“EPS”) Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. We apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses.  We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive. The following table sets forth the computation of basic and diluted EPS: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Six months ended June 30, </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1.5pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Net income (loss) </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(177,299) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">999,669  </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:01.90%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Cumulative dividend on convertible preferred stock </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(369,661) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(732,849) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Net income attributable to convertible preferred stock </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(167,539) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Earnings (net loss) attributable to common stockholders </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(546,960) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,333,116) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">99,281  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(4,607,417) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;"> Shares used for basic EPS-weighted average shares </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,581,330  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,450,392  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:24.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Effect of dilutive securities: </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Restricted Stock Units </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">8,087  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Stock Options, Appreciation Rights and Warrants </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">  — </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;"> Weighted average shares used in computing earnings (net loss) per share </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,581,330  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,793,583  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">22,458,479  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">21,702,597  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:25.50pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Basic EPS </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.02) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:45.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted EPS </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:10.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.02) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.11) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">0.00  </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(0.21) </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> </tr> </table></div> The following potential common shares were excluded from diluted EPS for the six months ended June 30, 2017 as they were antidilutive:  645,885 stock options and stock appreciation rights, 628,775 restricted stock units, and 38,779,119 warrants. In addition, the Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights or warrants in the calculation of diluted loss per common share for the three months ended June 30, 2017 or the three and six months ended June 30, 2016 because all such securities are anti-dilutive for the period. The Company had no unearned restricted shares during either period. As of June  30, 2017, the Company had 645,885 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $7.01 per share,  38,779,119 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.82 per share, 38,463,078 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock and accumulated dividends at an exercise price of $0.65 per share, and 636,862 shares of unvested restricted share units. <a name="eolPage9"></a> Recently Issued Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” or “Update”) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” This amendment is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification on the statement of cash flows. This update is effective for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company) and interim periods within those fiscal years, with earlier application permitted. The Company adopted this guidance in the first quarter of 2017.  The adoption of ASU 2016-09 did not materially impact the Company’s consolidated financial position, results of operations, equity or cash flows. In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory” regarding the subsequent measurement of inventory as part of its Simplification Initiative. This standard is effective for public companies for fiscal years beginning after December 15, 2016 (January 1, 2017 for the Company), including interim periods within those fiscal years. This Update should be applied prospectively, and early application is permitted as of the beginning of an interim or annual reporting period. The Company adopted this accounting standard update in the first quarter of 2017. The adoption of ASU 2015-11 did not materially impact the company’s results of operations, financial conditions, cash flows, or financial statement presentation. In February 2016, the FASB issued ASU 2016-02, “Leases (ASC 842),” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. ASC 842 supersedes the previous leases standard, ASC 840 Leases. The standard is effective for interim and annual periods beginning after December 31, 2018 (January 1, 2019 for the Company), with early adoption permitted. The Company is in the process of evaluating the impact of this accounting standard update. In August 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-15, to communicate amendments to FASB Account Standards Codification Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The ASU requires management to evaluate relevant conditions, events and certain management plans that are known or reasonably knowable as of the evaluation date when determining whether substantial doubt about an entity’s ability to continue as a going concern exists. Management will be required to make this evaluation for both annual and interim reporting periods. Management will have to make certain disclosures if it concludes that substantial doubt exists or when it plans to alleviate substantial doubt about the entity’s ability to continue as a going concern. The standard is effective for annual periods ending after December 15, 2016 and for interim reporting periods starting in the first quarter of 2017 (December 31, 2016 for the Company). Early adoption is permitted. The Company adopted this accounting standard update effective December 31, 2016 and provided the relevant disclosures in Note 1.  In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB’s and the International Accounting Standards Board’s current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. The Company will adopt ASU 2014-09 during the first quarter of 2018 and anticipates using the modified retrospective method that will result in a cumulative effect adjustment as of the date of adoption. Upon initial evaluation, management does not anticipate a significant change to its existing units of accounting which include systems, disposables and other accessories, royalty and other recurring revenue. The Company continues to evaluate other areas of the standard and its effect on the Company’s financial statements. </div> </div>

-21489927

-20058708

4015

205999

167539

19787007

151695

66081

19569231

151695

66081

19569231

16357444

35625

1819

16320000

35625

1819

16320000

21702597

21793583

22458479

22581330

21702597

21793583

22450392

22581330

EX-101.SCH 8 stxs-20170630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Prepaid Expenses And Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details) (Alternative) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Property And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) (Alternative) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Deferred Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis By Level) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Description Of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Prepaid Expenses And Other Current Assets link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Property And Equipment link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Deferred Revenue link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Long-Term Debt And Credit Facilities link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Convertible Preferred Stock And Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Product Warranty Provisions link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 12001 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary Of Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Prepaid Expenses And Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Property And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Deferred Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - Convertible Preferred Stock And Stockholder's Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 31603 - Disclosure - Product Warranty Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary Of Significant Accounting Policies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary Of Significant Accounting Policies (Computation Of Basic And Diluted EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Accrued Liabilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Long-Term Debt And Credit Facilities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Convertible Preferred Stock And Stockholders' Equity (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41103 - Disclosure - Convertible Preferred Stock And Stockholders' Equity (Summary Of Option And Stock Appreciation Rights Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41105 - Disclosure - Convertible Preferred Stock And Stockholders' Equity (Summary Of Restricted Stock Unit Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - Fair Value Measurements (Summary Of Changes In Fair Value Of Level 3 Financial Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - Product Warranty Provisions (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 stxs-20170630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 stxs-20170630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 stxs-20170630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Entity Registrant Name Entity Filer Category Entity Central Index Key Trading Symbol Amendment Flag Document Type Document Fiscal Period Focus Document Period End Date Document Fiscal Year Focus Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Balance Sheets [Abstract] Assets Abstract Assets Current assets [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable, net of allowance of $603,588 and $379,817 in 2017 and 2016, respectively Inventory, Net Total inventory Inventories Prepaid Expenses And Other Current Assets Prepaid expenses and other current assets Total current prepaid expenses and other assets Assets, Current Total current assets Property, Plant and Equipment, Net Net property and equipment Property and equipment, net Finite-Lived Intangible Assets, Net Intangible assets, net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Stockholders' Equity [Abstract] Liabilities and stockholders' deficit Current liabilities [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Total current accrued liabilities Accrued liabilities Deferred Revenue, Current Total current deferred revenue Deferred revenue Warrants and Rights Outstanding Warrants Warrants issued Liabilities, Current Total current liabilities Deferred Revenue, Noncurrent Less: Long-term deferred revenue Long-term deferred revenue Other Accrued Liabilities, Noncurrent Less: Long term accrued liabilities Other liabilities Liabilities Total liabilities Preferred Stock [Abstract] Preferred Stock [Abstract] Convertible Preferred stock: Preferred stock, par value $0.001; 10,000,000 shares authorized at 2011 and 2010, none outstanding at 2011 and 2010 Convertible Preferred stock, par value $0.001; 10,000,000 shares authorized ; 23,900 shares outstanding at 2017 and 2016 Stockholders' Equity Attributable to Parent [Abstract] Stockholders' deficit: Common Stock, Value, Issued Common stock, par value $0.001; 300,000,000 shares authorized, 22,612,043 and 22,063,582 shares issued at 2017 and 2016, respectively Additional Paid in Capital, Common Stock Additional paid in capital Treasury Stock, Common, Value Treasury stock, 4,015 shares at 2017 and 2016 Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total stockholders' deficit Liabilities and Stockholders' Equity Total liabilities and stockholders' deficit Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Treasury Stock, Common, Shares Treasury stock, shares Statements Of Operations [Abstract] Revenues [Abstract] Revenue: Aggregate revenue during the period from the sale of systems in the normal course of business, after deducting returns, allowances and discounts. Systems Revenue Systems Total revenue related to disposables and accessories sold and services rendered during the reporting period. Disposables Service And Accessories Revenue Disposables, service and accessories Revenues Total revenue Cost of Revenue [Abstract] Cost of revenue: Total costs related to systems produced and sold during the reporting period. Systems Cost Of Revenue Systems Total costs related to disposables and accessories sold and services rendered during the reporting period. Disposables, Service And Accessories Cost Of Revenue Disposables, service and accessories Cost of Revenue Total cost of revenue Gross Profit Gross margin Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Selling and Marketing Expense Sales and marketing General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Operating loss Other Nonoperating Income Other income Investment Income, Interest Interest income Interest Expense Interest expense Net Loss Net earnings (loss) Net income (loss) Preferred Stock Dividends, Income Statement Impact Cumulative dividend on convertible preferred stock Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Net income attributable to convertible preferred stock Net Income (Loss) Available to Common Stockholders, Basic Earnings (net loss) attributable to common stockholders Net Loss Per Share [Abstract] Earnings (net loss) per common share: Basic EPS Basic Diluted EPS Diluted Weighted Average Number Of Basic And Diluted Shares Outstanding Abstract Weighted average shares used in computing earnings (net loss) per common share: Denominator for basic EPS - weighted average shares Basic Shares used for basic EPS-weighted average shares Weighted average shares used in computing earnings (net loss) per share Diluted Statements Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net earnings (loss) to cash used in operating activities: Depreciation Amortization expense Amortization of intangibles Amortization of Financing Costs Amortization of deferred finance costs Share-based compensation Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Loss on asset disposal Warrant adjustment Adjustment of warrants Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Accounts receivable Accounts receivable Inventories Inventories Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other current assets Other assets Other assets Accounts payable Increase Decrease In Accrued Liabilities Accrued liabilities Increase Decrease In Deferred Revenue Deferred revenue Other liabilities Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities Purchase of equipment Purchase of fixed assets Net cash used in investing activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Payments of Financing Costs Payments of deferred financing costs Proceeds from revolving line of credit Proceeds from (payments of) revolving line of credit Repayments of Secured Debt Payments of Healthcare Royalty Partners debt Payments of debt Proceeds from Issuance of Common Stock Proceeds from issuance of stock Proceeds from (Repurchase of) Equity Proceeds from issuance of stock, net of issuance costs Net cash provided by financing activities Net cash provided by (used in) financing activities Net decrease in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Description Of Business [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Description Of Business Summary Of Significant Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Summary Of Significant Accounting Policies Inventories [Abstract] Inventory Disclosure [Text Block] Inventories Prepaid Expenses And Other Current Assets [Abstract] Other Current Assets [Text Block] Prepaid Expenses And Other Current Assets Property And Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property And Equipment Intangible Assets [Abstract] Intangible Assets Disclosure [Text Block] Intangible Assets Accrued Liabilities [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Liabilities Deferred Revenue [Abstract] Deferred Revenue Disclosure [Text Block] Deferred Revenue Long-Term Debt And Credit Facilities [Abstract] Long-term Debt [Text Block] Long-Term Debt And Credit Facilities Convertible Preferred Stock And Stockholders' Equity [Abstract] Shareholders' Equity and Share-based Payments [Text Block] Convertible Preferred Stock And Stockholders' Equity Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Product Warranty Provisions [Abstract] Product Warranty Disclosure [Text Block] Product Warranty Provisions Commitments And Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments And Contingencies Subsequent Events [Abstract] Schedule of Subsequent Events [Text Block] Subsequent Events Basis Of Presentation [Policy Text Block] Basis Of Presentation Fair Value of Financial Instruments, Policy [Policy Text Block] Financial Instruments Revenue Recognition And Cost Of Revenue Policy [Text Block] Revenue Recognition And Cost Of Revenue Policy [Text Block] Revenue And Costs Of Revenue Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Share-Based Compensation Earnings Per Share, Policy [Policy Text Block] Net Earnings (Loss) per Common Share ("EPS") New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Computation Of Basic And Diluted EPS Schedule of Inventory, Current [Table Text Block] Schedule Of Inventories Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Text Block] Schedule Of Prepaid Expenses And Other Current Assets Property, Plant and Equipment [Table Text Block] Schedule Of Property And Equipment Schedule of Accrued Liabilities [Table Text Block] Schedule Of Accrued Liabilities Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Schedule Of Deferred Revenue Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity [Table Text Block] Summary Of Option And Stock Appreciation Rights Activity Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Summary Of Restricted Stock Unit Activity Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Assets And Liabilities Measured At Fair Value On Recurring Basis By Level Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary Of Changes In Fair Value Of Level 3 Financial Liabilities Schedule of Product Warranty Liability [Table Text Block] Schedule Of Accrued Warranty Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Restricted Stock Units R S U [Member] Restricted Stock Units [Member] Warrant [Member] Warrants [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Share-based compensation, requisite service period Options To Purchase Common Stock Number of Options/SARs, Outstanding, March 31, 2017 Number of Options/SARs, Outstanding, December 31, 2016 Options and stock appreciation rights outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Outstanding, March 31, 2017 Weighted Average Exercise Price per Share, Outstanding, December 31, 2016 Weighted average exercise price Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive common shares excluded from the computation of diluted earnings per share Warrants Common stock issuable upon exercise Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrants Restricted shares outstanding Number of Restricted Stock Units, Outstanding, March 31, 2017 Number of Restricted Stock Units, Outstanding, December 31, 2016 Unvested restricted shares Deferred Finance Costs, Net Deferred financing costs Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Effect of diluted securities: Restricted stock units Inventory, Raw Materials Raw materials Inventory, Work in Process Work in process Inventory, Finished Goods Finished goods Inventory Valuation Reserves Reserve for obsolescence Prepaid Expense Prepaid expenses Debt Issuance Costs, Line of Credit Arrangements, Net Deferred financing costs Deposits Assets Deposits Prepaid Expense and Other Assets Total prepaid expenses and other assets Prepaid Expense and Other Assets, Noncurrent Less: Noncurrent prepaid expenses and other assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross Gross property and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: Accumulated depreciation Finite-Lived Intangible Assets, Gross Total intangible assets Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amortization Real Estate [Table] Real Estate [Line Items] Area of Real Estate Property Square feet of leased space Accrued Lease Termination Costs Remaining Accrued Lease Termination Costs Remaining Accrued lease termination costs remaining Lease Expiration Date Sublease expiration date Accrued Rent Current and NonCurrent Accrued rent Accrued costs of rent liability Employee-related Liabilities, Current Accrued salaries, bonus, and benefits EX-101.PRE 12 stxs-20170630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2017	Jul. 31, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	Stereotaxis, Inc.
Entity Filer Category	Smaller Reporting Company
Entity Central Index Key	0001289340
Trading Symbol	stxs
Amendment Flag	false
Document Type	10-Q
Document Fiscal Period Focus	Q2
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		22,753,121

XML 14 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 5,035,463	$ 8,501,392
Accounts receivable, net of allowance of $603,588 and $379,817 in 2017 and 2016, respectively	4,876,716	4,665,959
Inventories	4,984,115	5,381,103
Prepaid expenses and other current assets	617,412	855,295
Total current assets	15,513,706	19,403,749
Property and equipment, net	792,367	1,086,244
Intangible assets, net	336,908	436,569
Other assets	41,047	39,241
Total assets	16,684,028	20,965,803
Current liabilities:
Accounts payable	1,737,247	2,623,010
Accrued liabilities	3,887,511	4,491,164
Deferred revenue	8,101,667	8,751,336
Warrants	16,357,444	19,787,007
Total current liabilities	30,083,869	35,652,517
Long-term deferred revenue	377,076	522,329
Other liabilities	321,316	320,409
Total liabilities	30,782,261	36,495,255
Convertible Preferred stock:
Convertible Preferred stock, par value $0.001; 10,000,000 shares authorized ; 23,900 shares outstanding at 2017 and 2016	5,960,475	5,960,475
Stockholders' deficit:
Common stock, par value $0.001; 300,000,000 shares authorized, 22,612,043 and 22,063,582 shares issued at 2017 and 2016, respectively	22,612	22,064
Additional paid in capital	450,370,408	449,939,406
Treasury stock, 4,015 shares at 2017 and 2016	(205,999)	(205,999)
Accumulated deficit	(470,245,729)	(471,245,398)
Total stockholders' deficit	(20,058,708)	(21,489,927)
Total liabilities and stockholders' deficit	$ 16,684,028	$ 20,965,803

XML 15 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Balance Sheets [Abstract]
Accounts receivable, allowance	$ 603,588	$ 379,817
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	23,900	23,900
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	22,612,043	22,063,582
Treasury stock, shares	4,015	4,015

XML 16 R4.htm IDEA: XBRL DOCUMENT

Statements Of Operations - USD ($)	3 Months Ended		6 Months Ended
Statements Of Operations - USD ($)	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue:
Systems	$ 1,828,439	$ 935,978	$ 2,047,334	$ 3,010,997
Disposables, service and accessories	6,638,587	6,938,645	13,397,364	13,511,632
Total revenue	8,467,026	7,874,623	15,444,698	16,522,629
Cost of revenue:
Systems	920,517	395,898	1,140,961	1,478,996
Disposables, service and accessories	1,281,729	699,173	2,317,911	1,796,888
Total cost of revenue	2,202,246	1,095,071	3,458,872	3,275,884
Gross margin	6,264,780	6,779,552	11,985,826	13,246,745
Operating expenses:
Research and development	1,281,264	1,421,380	2,439,697	2,894,465
Sales and marketing	3,472,619	4,211,706	7,098,219	8,105,819
General and administrative	1,945,676	2,786,046	4,785,546	5,372,838
Total operating expenses	6,699,559	8,419,132	14,323,462	16,373,122
Operating loss	(434,779)	(1,639,580)	(2,337,636)	(3,126,377)
Other income	300,255	135,370	3,429,563	166,664
Interest income	1	140	9	362
Interest expense	(42,776)	(829,046)	(92,267)	(1,648,066)
Net income (loss)	(177,299)	(2,333,116)	999,669	(4,607,417)
Cumulative dividend on convertible preferred stock	(369,661)		(732,849)
Net income attributable to convertible preferred stock			(167,539)
Earnings (net loss) attributable to common stockholders	$ (546,960)	$ (2,333,116)	$ 99,281	$ (4,607,417)
Earnings (net loss) per common share:
Basic	$ (0.02)	$ (0.11)	$ 0.00	$ (0.21)
Diluted	$ (0.02)	$ (0.11)	$ 0.00	$ (0.21)
Weighted average shares used in computing earnings (net loss) per common share:
Basic	22,581,330	21,793,583	22,450,392	21,702,597
Diluted	22,581,330	21,793,583	22,458,479	21,702,597

XML 17 R5.htm IDEA: XBRL DOCUMENT

Statements Of Cash Flows - USD ($)	6 Months Ended
Statements Of Cash Flows - USD ($)	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Net earnings (loss)	$ 999,669	$ (4,607,417)
Adjustments to reconcile net earnings (loss) to cash used in operating activities:
Depreciation	277,402	185,802
Amortization of intangibles	99,661	99,660
Amortization of deferred finance costs	49,588	108,850
Share-based compensation	412,678	566,975
Loss on asset disposal	20,772
Adjustment of warrants	(3,429,563)	(166,664)
Changes in operating assets and liabilities:
Accounts receivable	(210,757)	1,318,967
Inventories	396,988	(806,755)
Prepaid expenses and other current assets	288,295	147,942
Other assets	(1,806)	(13,081)
Accounts payable	(885,763)	587,562
Accrued liabilities	(603,653)	(627,335)
Deferred revenue	(794,922)	(1,398,213)
Other liabilities	907	(5,307)
Net cash used in operating activities	(3,380,504)	(4,609,014)
Cash flows from investing activities
Purchase of fixed assets	(4,297)
Net cash used in investing activities	(4,297)
Cash flows from financing activities
Payments of deferred financing costs	(100,000)	(100,000)
Proceeds from (payments of) revolving line of credit		3,000,000
Payments of Healthcare Royalty Partners debt		(23,709)
Proceeds from issuance of stock, net of issuance costs	18,872	(2,770)
Net cash provided by (used in) financing activities	(81,128)	2,873,521
Net increase (decrease) in cash and cash equivalents	(3,465,929)	(1,735,493)
Cash and cash equivalents at beginning of period	8,501,392	5,593,582
Cash and cash equivalents at end of period	$ 5,035,463	$ 3,858,089

XML 18 R6.htm IDEA: XBRL DOCUMENT

Description Of Business	6 Months Ended
Description Of Business	Jun. 30, 2017
Description Of Business [Abstract]
Description Of Business	1. Description of Business Stereotaxis designs, manufactures and markets the Epoch Solution, which is an advanced remote robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias and coronary artery disease by enabling enhanced safety, efficiency and efficacy for catheter-based, or interventional, procedures. The Epoch Solution is comprised of the Niobe ES Remote Magnetic Navigation System (“Niobe ES system”), Odyssey Information Management Solution (“Odyssey Solution”), and the Vdrive Robotic Navigation System (“Vdrive system”), and related devices. The Niobe system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. As of June 30, 2017, the Company had an installed base of 128 Niobe ES systems. In addition to the Niobe system and its components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation and training. Our Vdrive system provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive system complements the Niobe ES system control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive system and the Vdrive Duo system. In addition to the Vdrive system and the Vdrive Duo system, we also manufacture and market various disposable components which can be manipulated by these systems. We promote the full Epoch Solution in a typical hospital implementation, subject to regulatory approvals or clearances. The full Epoch Solution implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and software licenses. In hospitals where the full Epoch Solution has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion. The core components of Stereotaxis systems, such as the Niobe system, Odyssey Solution, Cardiodrive and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and European Union. The V-CAS Deflect catheter advancement system has been CE Marked for sale in the European Union. We have alliances with each of Biosense Webster, Inc., Philips Medical Systems, and Siemens AG Medical Solutions, through which we integrate our Niobe system with their respective digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of such alliances, or the establishment of equivalent alternatives, is critical to our commercialization efforts. The commercial availability of currently compatible digital imaging fluoroscopy systems is unlikely to continue indefinitely and efforts are being made to ensure the availability of integrated next generation systems and/or equivalent alternatives; however, we cannot assure as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all. The Company believes the cash on hand at June 30, 2017 and expected borrowing capacity available will be sufficient to meet its obligations as they become due in the ordinary course of business for at least 12 months following the date these financial statements are issued. This evaluation assumes the Company is able to renew and has the ability to borrow under its asset based revolving credit facility which matures on March 31, 2018. The Company expects to be able to renew this facility at similar terms, as it has successfully done so in the past. There is no assurance that the revolving credit facility will be renewed in a timely manner, in amounts that are sufficient to meet the Company’s obligations as they become due, or on terms acceptable to the Company, or at all. The Company has sustained operating losses throughout its corporate history and expects that its 2017 expenses will exceed its 2017 gross margin. The Company expects to continue to incur operating losses and negative cash flows until revenues reach a level sufficient to support ongoing operations or expense reductions are in place. Accordingly, management has analyzed its planned operations to evaluate the Company’s ability to continue as a going concern. The Company’s liquidity needs will be largely determined by the success of clinical adoption within the installed base of Niobe systems as well as by new placements of capital systems. The Company’s plans for improving its liquidity conditions, which are probable of effectively being implemented, primarily include its ability to control the timing and spending of its operating expenses and raising additional funds through capital transactions. Specifically, cash outflows for operating expenses could be reduced or delayed by transitioning certain cash payments to stock payments, by reducing project expenses, or by reducing headcount. The Company also may consider raising cash through capital transactions, which could include either debt or equity financing.

XML 19 R7.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies

6 Months Ended

Jun. 30, 2017

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

Financial Instruments

Revenue and Costs of Revenue

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

Under our revenue recognition policy, a portion of revenue for Niobe systems, Vdrive systems and certain Odyssey systems is recognized upon delivery, provided that title has passed, there are no uncertainties regarding acceptance, persuasive evidence of an arrangement exists, the sales price is fixed and determinable, and collection of the related receivable is reasonably assured. Revenue is recognized for other types of Odyssey systems upon completion of installation, since there are no qualified third party installers. When installation is the responsibility of the customer, revenue from system sales is recognized upon shipment since these arrangements do not include an installation element or right of return privileges. The Company does not recognize revenue in situations in which inventory remains at a Stereotaxis warehouse or in situations in which title and risk of loss have not transferred to the customer. Amounts collected prior to satisfying the above revenue recognition criteria are reflected as deferred revenue. Revenue from services and license fees, whether sold individually or as a separate unit of accounting in a multiple-deliverable arrangement, is deferred and amortized over the service or license fee period, which is typically one year. Revenue from services is derived primarily from the sale of annual product maintenance plans. We recognize revenue from disposable device sales or accessories upon shipment and establish an appropriate reserve for returns. The return reserve, which is applicable only to disposable devices, is estimated based on historical experience which is periodically reviewed and updated as necessary. In the past, changes in estimate have had only a de minimis effect on revenue recognized in the period. We believe that the estimate is not likely to change significantly in the future.

Share-Based Compensation

Net Earnings (Loss) per Common Share (“EPS”)

The following table sets forth the computation of basic and diluted EPS:


		Three months ended June 30,				Six months ended June 30,
		2017		2016		2017		2016
Net income (loss)	$	(177,299)	$	(2,333,116)	$	999,669	$	(4,607,417)
Cumulative dividend on convertible preferred stock		(369,661)		—		(732,849)		—
Net income attributable to convertible preferred stock		—		—		(167,539)		—
Earnings (net loss) attributable to common stockholders	$	(546,960)	$	(2,333,116)	$	99,281	$	(4,607,417)

Shares used for basic EPS-weighted average shares		22,581,330		21,793,583		22,450,392		21,702,597
Effect of dilutive securities:		—		—		—		—
Restricted Stock Units		—		—		8,087		—
Stock Options, Appreciation Rights and Warrants		—		—		—		—

Weighted average shares used in computing earnings (net loss) per share		22,581,330		21,793,583		22,458,479		21,702,597
Basic EPS	$	(0.02)	$	(0.11)	$	0.00	$	(0.21)
Diluted EPS	$	(0.02)	$	(0.11)	$	0.00	$	(0.21)

Recently Issued Accounting Pronouncements

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers,” which converges the FASB’s and the International Accounting Standards Board’s current standards on revenue recognition. The standard provides companies with a single model to use in accounting for revenue arising from contracts with customers and supersedes current revenue guidance. The standard is effective for annual and interim periods beginning after December 15, 2017 (January 1, 2018 for the Company). The standard permits companies to either apply the adoption to all periods presented, or apply the requirements in the year of adoption through a cumulative adjustment. The Company will adopt ASU 2014-09 during the first quarter of 2018 and anticipates using the modified retrospective method that will result in a cumulative effect adjustment as of the date of adoption. Upon initial evaluation, management does not anticipate a significant change to its existing units of accounting which include systems, disposables and other accessories, royalty and other recurring revenue. The Company continues to evaluate other areas of the standard and its effect on the Company’s financial statements.

XML 20 R8.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2017

Inventories [Abstract]

Inventories

3. Inventories

Inventories consist of the following:


	June 30, 2017	December 31, 2016

Raw materials	$ 2,435,855	$ 2,397,430
Work in process	403,863	341,125
Finished goods	2,502,343	2,915,162
Reserve for obsolescence	(357,946)	(272,614)
Total inventory	$ 4,984,115	$ 5,381,103

XML 21 R9.htm IDEA: XBRL DOCUMENT

Prepaid Expenses And Other Current Assets

6 Months Ended

Jun. 30, 2017

Prepaid Expenses And Other Current Assets [Abstract]

Prepaid Expenses And Other Current Assets

4. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:



	June 30, 2017	December 31, 2016

Prepaid expenses	$ 328,404	$ 575,886
Deferred financing costs	75,068	24,658
Deposits	254,987	293,992
Total prepaid expenses and other assets	658,459	894,536
Less: Noncurrent prepaid expenses and other assets	(41,047)	(39,241)
Total current prepaid expenses and other assets	$ 617,412	$ 855,295

XML 22 R10.htm IDEA: XBRL DOCUMENT

Property And Equipment

6 Months Ended

Jun. 30, 2017

Property And Equipment [Abstract]

Property And Equipment

5. Property and Equipment

Property and equipment consist of the following:


	June 30,	December 31,
	2017	2016

Equipment	$ 7,258,587	$ 8,397,528
Equipment held for lease	0	303,412
Leasehold improvements	2,592,338	2,719,860
	9,850,925	11,420,800
Less: Accumulated depreciation	(9,058,558)	(10,334,556)
Net property and equipment	$ 792,367	$ 1,086,244

XML 23 R11.htm IDEA: XBRL DOCUMENT

Intangible Assets	6 Months Ended
Intangible Assets	Jun. 30, 2017
Intangible Assets [Abstract]
Intangible Assets	6. Intangible Assets As of June 30, 2017, the Company had total intangible assets of $3,221,069. Accumulated amortization at June 30, 2017, was $2,884,161.

XML 24 R12.htm IDEA: XBRL DOCUMENT

Accrued Liabilities

6 Months Ended

Jun. 30, 2017

Accrued Liabilities [Abstract]

Accrued Liabilities

7. Accrued Liabilities

Accrued liabilities consist of the following:


	June 30,	December 31,
	2017	2016

Accrued salaries, bonus, and benefits	$ 2,197,612	$ 2,452,183
Accrued rent	640,496	965,412
Accrued licenses and maintenance fees	573,378	561,450
Accrued warranties	181,308	222,845
Accrued taxes	267,164	219,017
Accrued professional services	112,500	180,450
Other	236,369	210,216
Total accrued liabilities	4,208,827	4,811,573
Less: Long term accrued liabilities	(321,316)	(320,409)
Total current accrued liabilities	$ 3,887,511	$ 4,491,164

XML 25 R13.htm IDEA: XBRL DOCUMENT

Deferred Revenue

6 Months Ended

Jun. 30, 2017

Deferred Revenue [Abstract]

Deferred Revenue

8. Deferred Revenue

Deferred revenue consists of the following:


	June 30,	December 31,
	2017	2016

Product shipped, revenue deferred	$ 665,726	$ 549,709
Customer deposits	1,455,000	2,910,000
Deferred service and license fees	6,358,017	5,813,956
Total deferred revenue	8,478,743	9,273,665
Less: Long-term deferred revenue	(377,076)	(522,329)
Total current deferred revenue	$ 8,101,667	$ 8,751,336

XML 26 R14.htm IDEA: XBRL DOCUMENT

Long-Term Debt And Credit Facilities	6 Months Ended
Long-Term Debt And Credit Facilities	Jun. 30, 2017
Long-Term Debt And Credit Facilities [Abstract]
Long-Term Debt And Credit Facilities	9. Long-Term Debt and Credit Facilities Revolving Line of Credit The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $10.0 million subject to the value of collateralized assets. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender. The facility was amended on March 27, 2015, extending the maturity date to March 31, 2018 and on May 10, 2016, the Company and the primary lender agreed to modify certain financial covenants. The amended agreement requires the Company to maintain a liquidity ratio greater than 1.50:1.00, excluding certain short term advances from the calculation, and a minimum tangible net worth of not less than (no worse than) negative $24.0 million for the quarters ended June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, and September 30, 2017; and not less than (no worse than) negative $24.5 million for the quarters ended December 31, 2017 and March 31, 2018. As of June 30, the Company is in compliance with its loan covenants. As of June 30, 2017, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit are made based on the borrowing capacity one week in arrears. As of June 30, 2017, the Company had a borrowing capacity of $3.9 million based on the Company’s collateralized assets. The Company’s total liquidity as of June 30, 2017, was $8.9 million which included cash and cash equivalents of $5.0 million. Healthcare Royalty Partners Debt In November 2011, the Company entered into a loan agreement with Healthcare Royalty Partners. Under the agreement the Company borrowed $15 million from Healthcare Royalty Partners. The Company was permitted to borrow up to an additional $5 million in the aggregate based on the achievement by the Company of certain milestones related to Niobe ES system sales in 2012. On August 8, 2012, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the nine months ended June 30, 2012. On January 31, 2013, the Company borrowed an additional $2.5 million based upon achievement of a milestone related to Niobe ES system sales for the twelve months ended December 31, 2012. The loan was to be repaid through, and secured by, royalties payable to the Company under its Development, Alliance and Supply Agreement with Biosense Webster, Inc. (the “Biosense Agreement”). The Biosense Agreement relates to the development and distribution of magnetically enabled catheters used with Stereotaxis' Niobe ES system in cardiac ablation procedures. Under the terms of the agreement, Healthcare Royalty Partners was entitled to receive 100% of all royalties due to the Company under the Biosense Agreement until the loan was repaid. The loan was a full recourse loan, scheduled to mature on December 31, 2018, and included interest at an annual rate of 16% payable quarterly with royalties received under the Biosense Agreement. If the payments received by the Company under the Biosense Agreement were insufficient to pay all amounts of interest due on the loan, then such deficiency would have increased the outstanding principal amount on the loan. The loan was also secured by certain assets and intellectual property of the Company. The agreement also contained customary affirmative and negative covenants. The use of payments due to the Company under the Biosense Agreement was approved by our primary lender. In September 2016, the Company extinguished the remainder of the debt of $18.1 million, net of deferred financing costs of approximately $0.3 million, as well as accrued interest of $0.5 million for $13.0 million based upon an agreement entered into with Healthcare Royalty Partners. Following the repayment of the loan obligation, the royalties under the Biosense Agreement are now paid to the Company. As a result of the debt extinguishment, the Company recognized a net gain of $5.6 million in 2016.

XML 27 R15.htm IDEA: XBRL DOCUMENT

Convertible Preferred Stock And Stockholders' Equity

6 Months Ended

Jun. 30, 2017

Convertible Preferred Stock And Stockholders' Equity [Abstract]

Convertible Preferred Stock And Stockholders' Equity

10. Convertible Preferred Stock and Stockholders’ Equity

Convertible Preferred Stock and Warrants

On December 2, 2016, 100 shares of convertible preferred stock plus accumulated dividends were converted into 155,439 common shares.

Listing Transfer to OTCQX® Best Market

On August 2, 2016, the Company received a determination letter from the Nasdaq Hearings Panel (the “Panel”) notifying the Company that its common stock would be delisted from The Nasdaq Capital Market (“Nasdaq”) and that suspension of trading in the shares would be effective at the open of business on August 4, 2016. The delisting was completed by the filing of a Form 25 Notification of Delisting with the Securities Exchange Commission by Nasdaq on November 10, 2016. The Panel made the determination to delist the Company’s common stock because the Company did not demonstrate compliance with the minimum $35 million market value of listed securities requirement for a period of ten consecutive trading days by August 1, 2016, as required by a decision previously issued by the Panel on May 2, 2016. The Company’s shares of common stock commenced trading on the OTCQX® Best Market on August 4, 2016 under the Company’s current ticker symbol of “STXS.”

Controlled Equity Offering

The Company entered into a Controlled Equity OfferingSM sales agreement (the “Sales Agreement”) in May 2014, as amended on March 26, 2015, with Cantor Fitzgerald & Co. (“Cantor”), as agent and/or principal, pursuant to which the Company could issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $18.0 million. The Company paid Cantor a commission of 3.0% of the gross proceeds from any common stock sold through the Sales Agreement.

Stock Award Plans

On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At June 30, 2017, the Company had 5,544,098 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

A summary of the option and stock appreciation rights activity for the six month period ended June 30, 2017 is as follows:


	Number of Options/SARs	Range of Exercise Price	Weighted Average Exercise Price per Share

Outstanding, December 31, 2016	671,887	$1.45 - $116.40	$8.77
Granted	10,000	$0.62	$0.62
Exercised	-	-	-
Forfeited	(36,002)	$2.15 - $116.40	$38.16
Outstanding, June 30, 2017	645,885	$0.62 - $54.90	$7.01

A summary of the restricted stock unit activity for the six month period ended June 30, 2017 is as follows:


	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value per Unit

Outstanding, December 31, 2016	1,167,099	$1.48
Granted	30,000	$0.68
Vested	(515,737)	$1.76
Forfeited	(44,500)	$1.51
Outstanding, June 30, 2017	636,862	$1.21

XML 28 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

6 Months Ended

Jun. 30, 2017

Fair Value Measurements [Abstract]

Fair Value Measurements

11. Fair Value Measurements

Level 1: Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2: Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3: Values are generated from model-based techniques that use significant assumptions not observable in the market.


	Fair Value Measurement Using
	Total		Quoted Prices in Active Markets for Identical Instruments (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)
Assets at June 30, 2017:
Cash equivalents	$	791	791	—	—
Total assets at fair value	$	—	—	—	—
Liabilities at June 30, 2017:
Warrants issued May 2012	$	1,819	—	—	1,819
Warrants issued August 2013		35,625	—	—	35,625
Warrants issued September 2016		16,320,000	—	—	16,320,000
Total liabilities at fair value:	$	16,357,444	—	—	16,357,444
Assets at December 31, 2016:
Cash equivalents	$	—	—	—	—
Total assets at fair value	$	—	—	—	—
Liabilities at December 31, 2016:
Warrants issued May 2012	$	66,081	—	—	66,081
Warrants issued August 2013		151,695	—	—	151,695
Warrants issued September 2016		19,569,231	—	—	19,569,231
Total liabilities at fair value:	$	19,787,007	—	—	19,787,007

Level 1

Level 2

The Company does not have any financial assets or liabilities classified as Level 2.

Level 3

The following table sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities for the six month period ended June 30, 2017:


	Warrants issued May 2012	Warrants issued August 2013	Warrants issued September 2016	Total Liabilities
Balance at beginning of period	$ 66,081	$ 151,695	$ 19,569,231	$ 19,787,007
Issues	-	-	-	-
Settlements	-	-	-	-
Revaluation	(64,262)	(116,070)	(3,249,231)	(3,429,563)
Balance at end of period	$ 1,819	$ 35,625	$ 16,320,000	$ 16,357,444

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 29 R17.htm IDEA: XBRL DOCUMENT

Product Warranty Provisions

6 Months Ended

Jun. 30, 2017

Product Warranty Provisions [Abstract]

Product Warranty Provisions

12. Product Warranty Provisions

The Company’s standard policy is to warrant all Niobe, Odyssey, and Vdrive systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

Accrued warranty, which is included in other accrued liabilities, consists of the following:


	June 30, 2017		December 31, 2016
Warranty accrual, beginning of the fiscal period	$	222,845	$	316,835
Accrual adjustment for product warranty		35,228		103,743
Payments made		(76,765)		(197,733)
Warranty accrual, end of the fiscal period	$	181,308	$	222,845

XML 30 R18.htm IDEA: XBRL DOCUMENT

Commitments And Contingencies	6 Months Ended
Commitments And Contingencies	Jun. 30, 2017
Commitments And Contingencies [Abstract]
Commitments And Contingencies	13. Commitments and Contingencies The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

XML 31 R19.htm IDEA: XBRL DOCUMENT

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	14. Subsequent Events None.

XML 32 R20.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Policy)

6 Months Ended

Jun. 30, 2017

Summary Of Significant Accounting Policies [Abstract]

Basis Of Presentation

Basis of Presentation

Financial Instruments

Revenue And Costs Of Revenue

Revenue and Costs of Revenue

The Company accounts for revenue using Accounting Standards Codification Topic 605-25, Multiple-Element Arrangements (“ASC 605-25”).

Share-Based Compensation

Net Earnings (Loss) per Common Share ("EPS")

Net Earnings (Loss) per Common Share (“EPS”)

The following table sets forth the computation of basic and diluted EPS:


		Three months ended June 30,				Six months ended June 30,
		2017		2016		2017		2016
Net income (loss)	$	(177,299)	$	(2,333,116)	$	999,669	$	(4,607,417)
Cumulative dividend on convertible preferred stock		(369,661)		—		(732,849)		—
Net income attributable to convertible preferred stock		—		—		(167,539)		—
Earnings (net loss) attributable to common stockholders	$	(546,960)	$	(2,333,116)	$	99,281	$	(4,607,417)

Shares used for basic EPS-weighted average shares		22,581,330		21,793,583		22,450,392		21,702,597
Effect of dilutive securities:		—		—		—		—
Restricted Stock Units		—		—		8,087		—
Stock Options, Appreciation Rights and Warrants		—		—		—		—

Weighted average shares used in computing earnings (net loss) per share		22,581,330		21,793,583		22,458,479		21,702,597
Basic EPS	$	(0.02)	$	(0.11)	$	0.00	$	(0.21)
Diluted EPS	$	(0.02)	$	(0.11)	$	0.00	$	(0.21)

Recently Issued Accounting Pronouncements

XML 33 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2017

Summary Of Significant Accounting Policies [Abstract]

Computation Of Basic And Diluted EPS


		Three months ended June 30,				Six months ended June 30,
		2017		2016		2017		2016
Net income (loss)	$	(177,299)	$	(2,333,116)	$	999,669	$	(4,607,417)
Cumulative dividend on convertible preferred stock		(369,661)		—		(732,849)		—
Net income attributable to convertible preferred stock		—		—		(167,539)		—
Earnings (net loss) attributable to common stockholders	$	(546,960)	$	(2,333,116)	$	99,281	$	(4,607,417)

Shares used for basic EPS-weighted average shares		22,581,330		21,793,583		22,450,392		21,702,597
Effect of dilutive securities:		—		—		—		—
Restricted Stock Units		—		—		8,087		—
Stock Options, Appreciation Rights and Warrants		—		—		—		—

Weighted average shares used in computing earnings (net loss) per share		22,581,330		21,793,583		22,458,479		21,702,597
Basic EPS	$	(0.02)	$	(0.11)	$	0.00	$	(0.21)
Diluted EPS	$	(0.02)	$	(0.11)	$	0.00	$	(0.21)

XML 34 R22.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

6 Months Ended

Jun. 30, 2017

Inventories [Abstract]

Schedule Of Inventories


	June 30, 2017	December 31, 2016

Raw materials	$ 2,435,855	$ 2,397,430
Work in process	403,863	341,125
Finished goods	2,502,343	2,915,162
Reserve for obsolescence	(357,946)	(272,614)
Total inventory	$ 4,984,115	$ 5,381,103

XML 35 R23.htm IDEA: XBRL DOCUMENT

Prepaid Expenses And Other Current Assets (Tables)

6 Months Ended

Jun. 30, 2017

Prepaid Expenses And Other Current Assets [Abstract]

Schedule Of Prepaid Expenses And Other Current Assets



	June 30, 2017	December 31, 2016

Prepaid expenses	$ 328,404	$ 575,886
Deferred financing costs	75,068	24,658
Deposits	254,987	293,992
Total prepaid expenses and other assets	658,459	894,536
Less: Noncurrent prepaid expenses and other assets	(41,047)	(39,241)
Total current prepaid expenses and other assets	$ 617,412	$ 855,295

XML 36 R24.htm IDEA: XBRL DOCUMENT

Property And Equipment (Tables)

6 Months Ended

Jun. 30, 2017

Property And Equipment [Abstract]

Schedule Of Property And Equipment


	June 30,	December 31,
	2017	2016

Equipment	$ 7,258,587	$ 8,397,528
Equipment held for lease	0	303,412
Leasehold improvements	2,592,338	2,719,860
	9,850,925	11,420,800
Less: Accumulated depreciation	(9,058,558)	(10,334,556)
Net property and equipment	$ 792,367	$ 1,086,244

XML 37 R25.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Tables)

6 Months Ended

Jun. 30, 2017

Accrued Liabilities [Abstract]

Schedule Of Accrued Liabilities


	June 30,	December 31,
	2017	2016

Accrued salaries, bonus, and benefits	$ 2,197,612	$ 2,452,183
Accrued rent	640,496	965,412
Accrued licenses and maintenance fees	573,378	561,450
Accrued warranties	181,308	222,845
Accrued taxes	267,164	219,017
Accrued professional services	112,500	180,450
Other	236,369	210,216
Total accrued liabilities	4,208,827	4,811,573
Less: Long term accrued liabilities	(321,316)	(320,409)
Total current accrued liabilities	$ 3,887,511	$ 4,491,164

XML 38 R26.htm IDEA: XBRL DOCUMENT

Deferred Revenue (Tables)

6 Months Ended

Jun. 30, 2017

Deferred Revenue [Abstract]

Schedule Of Deferred Revenue


	June 30,	December 31,
	2017	2016

Product shipped, revenue deferred	$ 665,726	$ 549,709
Customer deposits	1,455,000	2,910,000
Deferred service and license fees	6,358,017	5,813,956
Total deferred revenue	8,478,743	9,273,665
Less: Long-term deferred revenue	(377,076)	(522,329)
Total current deferred revenue	$ 8,101,667	$ 8,751,336

XML 39 R27.htm IDEA: XBRL DOCUMENT

Convertible Preferred Stock And Stockholder's Equity (Tables)

6 Months Ended

Jun. 30, 2017

Convertible Preferred Stock And Stockholders' Equity [Abstract]

Summary Of Option And Stock Appreciation Rights Activity


	Number of Options/SARs	Range of Exercise Price	Weighted Average Exercise Price per Share

Outstanding, December 31, 2016	671,887	$1.45 - $116.40	$8.77
Granted	10,000	$0.62	$0.62
Exercised	-	-	-
Forfeited	(36,002)	$2.15 - $116.40	$38.16
Outstanding, June 30, 2017	645,885	$0.62 - $54.90	$7.01

Summary Of Restricted Stock Unit Activity


	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value per Unit

Outstanding, December 31, 2016	1,167,099	$1.48
Granted	30,000	$0.68
Vested	(515,737)	$1.76
Forfeited	(44,500)	$1.51
Outstanding, June 30, 2017	636,862	$1.21

XML 40 R28.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2017

Fair Value Measurements [Abstract]

Assets And Liabilities Measured At Fair Value On Recurring Basis By Level


	Fair Value Measurement Using
	Total		Quoted Prices in Active Markets for Identical Instruments (Level 1)	Significant Other Observable Inputs (Level 2)	Significant Unobservable Inputs (Level 3)
Assets at June 30, 2017:
Cash equivalents	$	791	791	—	—
Total assets at fair value	$	—	—	—	—
Liabilities at June 30, 2017:
Warrants issued May 2012	$	1,819	—	—	1,819
Warrants issued August 2013		35,625	—	—	35,625
Warrants issued September 2016		16,320,000	—	—	16,320,000
Total liabilities at fair value:	$	16,357,444	—	—	16,357,444
Assets at December 31, 2016:
Cash equivalents	$	—	—	—	—
Total assets at fair value	$	—	—	—	—
Liabilities at December 31, 2016:
Warrants issued May 2012	$	66,081	—	—	66,081
Warrants issued August 2013		151,695	—	—	151,695
Warrants issued September 2016		19,569,231	—	—	19,569,231
Total liabilities at fair value:	$	19,787,007	—	—	19,787,007

Summary Of Changes In Fair Value Of Level 3 Financial Liabilities


	Warrants issued May 2012	Warrants issued August 2013	Warrants issued September 2016	Total Liabilities
Balance at beginning of period	$ 66,081	$ 151,695	$ 19,569,231	$ 19,787,007
Issues	-	-	-	-
Settlements	-	-	-	-
Revaluation	(64,262)	(116,070)	(3,249,231)	(3,429,563)
Balance at end of period	$ 1,819	$ 35,625	$ 16,320,000	$ 16,357,444

XML 41 R29.htm IDEA: XBRL DOCUMENT

Product Warranty Provisions (Tables)

6 Months Ended

Jun. 30, 2017

Product Warranty Provisions [Abstract]

Schedule Of Accrued Warranty


	June 30, 2017		December 31, 2016
Warranty accrual, beginning of the fiscal period	$	222,845	$	316,835
Accrual adjustment for product warranty		35,228		103,743
Payments made		(76,765)		(197,733)
Warranty accrual, end of the fiscal period	$	181,308	$	222,845

XML 42 R30.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Narrative) (Details) - $ / shares	6 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of warrants	$ 0.70
Stock Options And Stock Appreciation Rights [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, requisite service period	4 years
Options and stock appreciation rights outstanding	645,885	671,887
Weighted average exercise price	$ 7.01	$ 8.77
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issuable upon exercise	38,779,119
Exercise price of warrants	$ 0.82
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares	636,862	1,167,099
Stock Options And Stock Appreciation Rights [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive common shares excluded from the computation of diluted earnings per share	645,885
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive common shares excluded from the computation of diluted earnings per share	628,775
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Anti-dilutive common shares excluded from the computation of diluted earnings per share	38,779,119
Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issuable upon exercise	38,463,078
Exercise price of warrants	$ 0.65

XML 43 R31.htm IDEA: XBRL DOCUMENT

Summary Of Significant Accounting Policies (Computation Of Basic And Diluted EPS) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Summary Of Significant Accounting Policies [Abstract]
Net earnings (loss)	$ (177,299)	$ (2,333,116)	$ 999,669	$ (4,607,417)
Cumulative dividend on convertible preferred stock	(369,661)		(732,849)
Net income attributable to convertible preferred stock			(167,539)
Earnings (net loss) attributable to common stockholders	$ (546,960)	$ (2,333,116)	$ 99,281	$ (4,607,417)
Shares used for basic EPS-weighted average shares	22,581,330	21,793,583	22,450,392	21,702,597
Effect of diluted securities: Restricted stock units			8,087
Weighted average shares used in computing earnings (net loss) per share	22,581,330	21,793,583	22,458,479	21,702,597
Basic EPS	$ (0.02)	$ (0.11)	$ 0.00	$ (0.21)
Diluted EPS	$ (0.02)	$ (0.11)	$ 0.00	$ (0.21)

XML 44 R32.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Inventories [Abstract]
Raw materials	$ 2,435,855	$ 2,397,430
Work in process	403,863	341,125
Finished goods	2,502,343	2,915,162
Reserve for obsolescence	(357,946)	(272,614)
Total inventory	$ 4,984,115	$ 5,381,103

XML 45 R33.htm IDEA: XBRL DOCUMENT

Prepaid Expenses And Other Current Assets (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Prepaid Expenses And Other Current Assets [Abstract]
Prepaid expenses	$ 328,404	$ 575,886
Deferred financing costs	75,068	24,658
Deposits	254,987	293,992
Total prepaid expenses and other assets	658,459	894,536
Less: Noncurrent prepaid expenses and other assets	(41,047)	(39,241)
Total current prepaid expenses and other assets	$ 617,412	$ 855,295

XML 46 R34.htm IDEA: XBRL DOCUMENT

Property And Equipment (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 9,850,925	$ 11,420,800
Less: Accumulated depreciation	(9,058,558)	(10,334,556)
Net property and equipment	792,367	1,086,244
Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	7,258,587	8,397,528
Equipment Held For Lease [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	0	303,412
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross property and equipment	$ 2,592,338	$ 2,719,860

XML 47 R35.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details)	Jun. 30, 2017 USD ($)
Intangible Assets [Abstract]
Total intangible assets	$ 3,221,069
Accumulated amortization	$ 2,884,161

XML 48 R36.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Narrative) (Details)	6 Months Ended
Accrued Liabilities (Narrative) (Details)	Jun. 30, 2017 USD ($) ft²	Jan. 31, 2017 USD ($) ft²	Dec. 31, 2016 USD ($)	Aug. 31, 2016 USD ($) ft²	Dec. 31, 2015 ft²	Sep. 30, 2013 USD ($) ft²
Real Estate [Line Items]
Accrued costs of rent liability	$ 640,496		$ 965,412
Office [Member]
Real Estate [Line Items]
Square feet of leased space \| ft²	52,000				3,152
Sublease expiration date	Dec. 31, 2018
Demonstration And Assembly [Member]
Real Estate [Line Items]
Square feet of leased space \| ft²	12,000
Unimproved [Member]
Real Estate [Line Items]
Square feet of leased space \| ft²						13,000
Accrued lease termination costs remaining	$ 138,528
Accrued costs of rent liability						$ 515,138
Office Sublease [Member]
Real Estate [Line Items]
Square feet of leased space \| ft²				11,000
Accrued lease termination costs remaining	$ 38,633
Sublease expiration date	Dec. 31, 2018
Accrued costs of rent liability				$ 40,972
Office Sublease, January 2017 [Member]
Real Estate [Line Items]
Square feet of leased space \| ft²		16,000
Sublease expiration date	Dec. 31, 2018
Accrued costs of rent liability		$ 28,208

XML 49 R37.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Schedule Of Accrued Liabilities) (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2015
Accrued Liabilities [Abstract]
Accrued salaries, bonus, and benefits	$ 2,197,612	$ 2,452,183
Accrued rent	640,496	965,412
Accrued licenses and maintenance fees	573,378	561,450
Accrued warranties	181,308	222,845	$ 316,835
Accrued taxes	267,164	219,017
Accrued professional services	112,500	180,450
Other	236,369	210,216
Total accrued liabilities	4,208,827	4,811,573
Less: Long term accrued liabilities	(321,316)	(320,409)
Total current accrued liabilities	$ 3,887,511	$ 4,491,164

XML 50 R38.htm IDEA: XBRL DOCUMENT

Deferred Revenue (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	$ 8,478,743	$ 9,273,665
Less: Long-term deferred revenue	(377,076)	(522,329)
Total current deferred revenue	8,101,667	8,751,336
Product Shipped, Revenue Deferred [Member]
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	665,726	549,709
Customer Deposits [Member]
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	1,455,000	2,910,000
Deferred Service And License Fees [Member]
Deferred Revenue Arrangement [Line Items]
Total deferred revenue	$ 6,358,017	$ 5,813,956

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References + Details

- Definition

The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References + Details

XML 51 R39.htm IDEA: XBRL DOCUMENT

Long-Term Debt And Credit Facilities (Narrative) (Details)			1 Months Ended		6 Months Ended		12 Months Ended
	Jan. 31, 2013 USD ($)	Aug. 08, 2012 USD ($)	Sep. 30, 2016 USD ($)	Nov. 30, 2011 USD ($)	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)	May 10, 2016 USD ($)	Dec. 31, 2015 USD ($)
Debt Instrument [Line Items]
Cash and cash equivalents					$ 5,035,463	$ 3,858,089	$ 8,501,392		$ 5,593,582
Payments of debt						$ 23,709	13,000,000
Healthcare Royalty Partners Debt [Member]
Debt Instrument [Line Items]
Amount of debt extinguished			$ 18,100,000
Deferred financing costs			300,000
Accrued interest			500,000
Payments of debt			$ 13,000,000
Gain on debt extinguishment							$ 5,600,000
Term Loan [Member] \| Healthcare Royalty Partners Debt [Member]
Debt Instrument [Line Items]
Amount borrowed	$ 2,500,000	$ 2,500,000		$ 15,000,000
Additional amount which may be borrowed				$ 5,000,000
Percentage of royalties entitled to receive				100.00%
Maturity date					Dec. 31, 2018
Annual interest rate				16.00%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity					$ 10,000,000
Line of credit facility, maturity date					Mar. 31, 2018
Minimum tangible net worth requirement, period one								$ (24,000,000)
Minimum tangible net worth requirement, period two								$ (24,500,000)
Total liquidity					$ 8,900,000
Line of credit facility, amount outstanding					0
Line of credit facility, current borrowing capacity					$ 3,900,000
Minimum [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Liquidity ratio								1.50

XML 52 R40.htm IDEA: XBRL DOCUMENT

Convertible Preferred Stock And Stockholders' Equity (Narrative) (Details)						1 Months Ended		6 Months Ended		12 Months Ended
	May 23, 2017 shares	Sep. 29, 2016 USD ($) shares	May 24, 2016 shares	Jun. 10, 2014 shares	Jun. 05, 2013 shares	Sep. 30, 2016 USD ($)	May 31, 2014 USD ($)	Jun. 30, 2017 USD ($) $ / shares item shares	Jun. 30, 2016 USD ($)	Dec. 31, 2016 USD ($) $ / shares shares
Shareholders' Equity and Share-based Payments [Line Items]
Votes per share \| item								1
Dividends declared								$ 0
Dividends paid								$ 0
Proceeds from preferred stock and warrants issued, gross		$ 24,000,000
Preferred stock, shares issued \| shares		24,000
Preferred stock, par value \| $ / shares								$ 0.001		$ 0.001
Preferred Stock, Liquidation Preference, Value								$ 1,000
Common stock issuable from warrants \| shares		36,923,078
Proceeds from preferred stocks and warrants, net										$ 23,000,000
Payments of debt									$ 23,709	13,000,000
Preferred stock dividend rate								6.00%
Preferred stock, conversion price \| $ / shares								$ 0.65
Preferred stock redemption, triggering event, Percent of common stock sold threshold								50.00%
Preferred stock, Accretion of dicount										$ 6,100,000
Exercise price of warrants \| $ / shares								$ 0.70
Warrant term								180 days
Increase in number of shares authorized for issuance under the Plan \| shares	4,000,000		1,500,000	1,000,000	1,000,000
Total compensation cost not yet recognized								$ 900,000
Weighted average amortization period of total compensation cost not yet recognized								4 years
Remaining shares available for issuance \| shares								5,544,098
Convertible Preferred Stock [Member]
Shareholders' Equity and Share-based Payments [Line Items]
Shares converted \| shares										100
Common Stock [Member]
Shareholders' Equity and Share-based Payments [Line Items]
Shares issued in conversion \| shares										155,439
Sales Agreement [Member]
Shareholders' Equity and Share-based Payments [Line Items]
Aggregate gross sales price							$ 18,000,000
Commission percentage of gross proceeds							3.00%
Proceeds from issuance of stock										$ 0
Warrants [Member]
Shareholders' Equity and Share-based Payments [Line Items]
Exercise price of warrants \| $ / shares								$ 0.82
Restricted Stock Units [Member]
Shareholders' Equity and Share-based Payments [Line Items]
Restricted shares outstanding \| shares								636,862		1,167,099
Healthcare Royalty Partners Debt [Member]
Shareholders' Equity and Share-based Payments [Line Items]
Payments of debt						$ 13,000,000

XML 53 R41.htm IDEA: XBRL DOCUMENT

Convertible Preferred Stock And Stockholders' Equity (Summary Of Option And Stock Appreciation Rights Activity) (Details) - Stock Options And Stock Appreciation Rights [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options/SARs, Outstanding, December 31, 2016	671,887
Number of Options/SARs, Granted	10,000
Number of Options/SARs, Exercised
Number of Options/SARs, Forfeited	(36,002)
Number of Options/SARs, Outstanding, March 31, 2017	645,885	671,887
Weighted Average Exercise Price per Share, Outstanding, December 31, 2016	$ 8.77
Weighted Average Exercise Price per Share, Granted	0.62
Weighted Average Exercise Price per Share, Exercised
Weighted Average Exercise Price per Share, Forfeited	38.16
Weighted Average Exercise Price per Share, Outstanding, March 31, 2017	7.01	$ 8.77
$1.45 - $116.40 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Lower Limit		1.45
Range of Exercise Price, Upper Limit		$ 116.40
$0.62 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Upper Limit	0.62
$2.15 - $116.40 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Lower Limit	2.15
Range of Exercise Price, Upper Limit	116.40
$0.62 - $54.90 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Price, Lower Limit	0.62
Range of Exercise Price, Upper Limit	$ 54.90

XML 54 R42.htm IDEA: XBRL DOCUMENT

Convertible Preferred Stock And Stockholders' Equity (Summary Of Restricted Stock Unit Activity) (Details) - Restricted Stock Units [Member]	6 Months Ended
	Jun. 30, 2017 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Restricted Stock Units, Outstanding, December 31, 2016 \| shares	1,167,099
Number of Restricted Stock Units, Granted \| shares	30,000
Number of Restricted Stock Units, Vested \| shares	(515,737)
Number of Restricted Stock Units, Forfeited \| shares	(44,500)
Number of Restricted Stock Units, Outstanding, March 31, 2017 \| shares	636,862
Weighted Average Grant Date Fair Value per Unit, Outstanding, December 31, 2016 \| $ / shares	$ 1.48
Weighted Average Grant Date Fair Value per Unit, Granted \| $ / shares	0.68
Weighted Average Grant Date Fair Value per Unit, Vested \| $ / shares	1.76
Weighted Average Grant Date Fair Value per Unit, Forfeited \| $ / shares	1.51
Weighted Average Grant Date Fair Value per Unit, Outstanding, March 31, 2017 \| $ / shares	$ 1.21

XML 55 R43.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Narrative) (Details) - USD ($)	6 Months Ended
Fair Value Measurements (Narrative) (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 791
Financial assets
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	791	0
Financial assets
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Financial assets
Significant Unobservable Inputs (Level 3) [Member] \| Warrants Issued September 2016 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant expiration date	Sep. 01, 2021
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Financial assets
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant expiration date	May 01, 2018
Volatility rate	79.92%
Risk-free interest rate	1.24%
Closing stock price	$ 0.58
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant expiration date	Nov. 01, 2018
Volatility rate	92.83%
Risk-free interest rate	1.24%
Closing stock price	$ 0.58
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued September 2016 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Volatility rate	117.82%
Risk-free interest rate	1.89%
Closing stock price	$ 0.58

XML 56 R44.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis By Level) (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 791
Total assets at fair value
Warrants issued	16,357,444	19,787,007
Total liabilities at fair value	16,357,444	19,787,007
Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	1,819	66,081
Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	35,625	151,695
Warrants Issued September 2016 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	16,320,000	19,569,231
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	791	0
Total assets at fair value
Total liabilities at fair value
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Quoted Prices In Active Markets For Identical Instruments (Level 1) [Member] \| Recurring [Member] \| Warrants Issued September 2016 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Total assets at fair value
Total liabilities at fair value
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Significant Other Observable Inputs (Level 2) [Member] \| Recurring [Member] \| Warrants Issued September 2016 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents
Total assets at fair value
Total liabilities at fair value	16,357,444	19,787,007
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued May 2012 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	1,819	66,081
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued August 2013 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	35,625	151,695
Significant Unobservable Inputs (Level 3) [Member] \| Recurring [Member] \| Warrants Issued September 2016 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants issued	$ 16,320,000	$ 19,569,231

XML 57 R45.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Summary Of Changes In Fair Value Of Level 3 Financial Liabilities) (Details)	6 Months Ended
	Jun. 30, 2017 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	$ 19,787,007
Issues
Settlements
Revaluation	(3,429,563)
Balance at end of period	16,357,444
Warrants Issued May 2012 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	66,081
Issues
Settlements
Revaluation	(64,262)
Balance at end of period	1,819
Warrants Issued August 2013 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	151,695
Issues
Settlements
Revaluation	(116,070)
Balance at end of period	35,625
Warrants Issued September 2016 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	19,569,231
Issues
Settlements
Revaluation	(3,249,231)
Balance at end of period	$ 16,320,000

XML 58 R46.htm IDEA: XBRL DOCUMENT

Product Warranty Provisions (Details) - USD ($)	6 Months Ended	12 Months Ended
Product Warranty Provisions (Details) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Product Warranty Provisions [Abstract]
Standard product warranty coverage term	1 year
Warranty accrual, beginning of the fiscal period	$ 222,845	$ 316,835
Accrual adjustment for product warranty	35,228	103,743
Payments made	(76,765)	(197,733)
Warranty accrual, end of the fiscal period	$ 181,308	$ 222,845

EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

~~&UL4$L! A0#% @ M>5D*2XBP+^]]30 S'T$ !4 ( !.QD! '-T>',M,C Q-S V M,S!?;&%B+GAM;%!+ 0(4 Q0 ( 'E9"DNW5?FZR34 .O\ P 5 M " >MF 0!S='AS+3(P,3~~